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Abstract
The transfusion of blood products can lead to life-threatening complications after surgery. In
addition, blood products are a scarce and expensive resource. Even though anemia in coronary
artery bypass surgery patients is currently undertreated, research has shown that the intravenous
infusion of iron products, as well as a single dose of erythropoietin-alpha prior to surgery,
decreases the amount of blood products used in the perioperative setting. The goal of this pilot
project was to increase the number of patients screened for anemia, and if necessary, treated
prior to coronary artery bypass graft surgery.
Methods: This was a practice improvement, pilot project within a preoperative assessment
center in a large Midwestern health system. The population included outpatient coronary artery
bypass graft surgical patients. The presence of anemia was determined prior to the required
cardiac catheterization before coronary artery bypass graft surgery. Through a new process,
patients diagnosed with anemia were referred to the preoperative assessment center for
optimization and treatment management. The results of this quality improvement project showed
an increase in the number of patients who received treatment for their anemia prior to surgery.
Conclusions: The literature suggests that a decreased use of blood products will result in fewer
complications following cardiac surgery. While this pilot project did not show a statistical
difference in the amount of blood products used, there was a clinically meaningful improvement
as the new process for anemia management increased the number of patients treated for anemia
prior to surgery.
Implications: This new referral process was successful in treating preoperative anemia.
Continued improvement in the treatment of anemia is needed to decrease the number of postsurgical complications that may arise from anemia in this population of coronary artery bypass
graft patients.
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Preoperative Anemia Management in Adult Outpatient Coronary Artery Bypass Graft Surgical
Patients to Improve Treatment of Preoperative Anemia
Anemia is a condition where the amount of hemoglobin circulating in the blood is
inadequate to meet the body’s physiologic needs. According to the World Health Organization
(WHO) (2008), anemia is defined as a hemoglobin concentration of less than 12 g/dL in nonpregnant women and less than 13 g/dL in men. While there are many conditions that can lead to
anemia, approximately 50% of occurrences are due to iron deficiency (WHO, 2008). Iron
deficiency anemia is most often caused by malnutrition and is the most common form of anemia,
followed closely by chronic disease anemia caused by inflammation or cancer (Peters,
Ellermann, & Steinbicker, 2018). Anemia caused by inflammation may reduce iron availability,
erythropoietin production in the kidney, and may result in a diminished bone marrow response
to erythropoietin (Peters et al., 2018). Preoperative anemia is common among cardiac surgical
patients with multiple comorbidities or advanced age. Moreover, major surgical procedures, such
as cardiac surgery, may result in considerable blood loss either intra- or post-procedure, which
can also result in anemia.
The treatment for iron deficiency anemia includes oral or intravenous (IV) iron
supplementation, erythropoietin-alpha (EPO), or allogeneic red blood cell transfusion (aRBCt).
A number of patients who have anemia due to blood loss require aRBCt. The likelihood of
needing a blood transfusion is increased if preoperative anemia exists (Weltert et al., 2015). It is
important to diagnose and treat anemia, as it is associated with poor outcomes after cardiac and
non-cardiac surgery and can lead to increased length of hospital stay, adverse effects and
complications from surgery, and mortality (Clevenger et al., 2016; dos Santos et al., 2013; Hung,
Besser, Sharples, Nair, & Klein, 2011).
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Even though aRBCt can improve oxygen delivery quickly, it is not the treatment of
choice because of the associated complications, such as atrial fibrillation, stroke, respiratory
infections, sepsis, myocardial infarction, and death (dos Santos et al., 2013; dos Santos, et al.,
2014). For example, the use of aRBCt can impact increased postoperative mortality by 70% for
patients who have cardiac surgery (dos Santos et al., 2014). Despite efforts to reduce aRBCt in
cardiac surgery, it remains a common practice. Other therapies, such as the administration of iron
therapy, whether oral or IV, in combination with EPO or as a single therapy, has been shown to
increase hemoglobin concentration and reduce the use of aRBCt (Clevenger et al., 2016;
Gurusamy, Nagendran, Broadhurst, Anker, & Richards, 2014; Lin, Lin, & Tran, 2013; Litton,
Xiao, & Ho, 2013; Peters et al., 2018). Understanding the pathophysiology of functional iron
deficiency is important when choosing to use EPO or iron supplementation to treat preoperative
anemia as the origins of anemia change the course of treatment. A single dose administration of
EPO prior to cardiac surgery has been shown to be effective in minimizing the need for aRBCt
without increasing adverse events (Cladellas et al., 2012; Weltert et al., 2015; Yoo et al., 2011)
In addition to the complications of aRBCt, cost is also a burden. The average cost of
aRBCt, when including all of the process steps, staff, and overhead cost, is $761 ± $294 per
transfusion (Shander et al., 2010). Blood products are also a scarce resource. In July 2018, the
American Red Cross reported a critical blood shortage that resulted in an emergency call for
eligible donors (The American National Red Cross, 2018). Blood donations fell short of
expectations in May and June 2018, resulting in 61,000 fewer donations than needed (The
American National Red Cross, 2018). Due to the scarcity of blood and the associated
complications, safe and effective strategies to reduce aRBCt are needed.
The purpose of this project was to implement an evidence-based practice improvement
initiative to improve the treatment of iron deficiency anemia prior to coronary artery bypass
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(CABG) surgery in a large Midwestern health system (MHS). Evidence regarding the assessment
of the current state of the Midwestern health system is included.
Current Practice
The process used to assess preoperative patients for anemia in MHS was evaluated.
Current practice included patient identification in the cardiac catheterization lab (cath lab) as a
possible candidate for CABG by the interventional cardiologist. From there, a registered nurse
within interventional cardiology services ordered the appropriate tests and referred the patient to
cardiothoracic surgery (CTS) for evaluation. After the cardiothoracic surgeon met with the
patient, the surgeon determined if surgery was the appropriate intervention. If surgery was
indicated, it was scheduled within two to three weeks of the initial surgical consultation. The
patient was then referred to the primary care provider for preoperative assessment and
optimization of chronic diseases prior to surgery. The provider optimizes existing medical issues
and recommends management of them in the perioperative period in coordination with other
providers involved in care.
Society of Thoracic Surgeon’s Data
The Society of Thoracic Surgeon’s (STS) National Database was established as an
initiative to improve patient safety and quality of care among cardiothoracic surgeons. The STS
Adult Cardiac Surgery Database is the world’s leading clinical outcomes registry for adult
cardiac surgery (D’Agostino et al., 2018). The database includes both national and specific
organization data (D’Agostino et al., 2018). As of June 2018, 1081 organizations in the United
States have participated in this database (D’Agostino et al., 2018). MHS uses the database as a
benchmark to guide practice within CTS.
According to the STS 2018 data, 38% of all patients (inpatient and outpatient) in MHS
who undergo cardiac surgery are anemic at the time of surgery. This is somewhat higher than a
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large multicenter cohort study where the overall prevalence of preoperative anemia was 26%
(Karkouti, Wijeysundera, & Beattie, 2008). Further, approximately 30% of patients in MHS
from the outpatient setting who undergo cardiac surgery were anemic. Of these 30% who were
anemic, only 17% of outpatient CABG patients were identified as anemic prior to surgery and
treated with oral iron supplements, vitamin B-12, and/or EPO injections. Improvement in
identification and treatment of anemia preoperatively was needed.
Assessment of the Health System
Model Overview
The Burke and Litwin Model of Organizational Performance and Change (1992)
framework and a SWOT analysis were used to guide the organizational assessment for this
project (see Appendix A). The Burke and Litwin model (1992) outlines 12 elements that may
affect the overall success of an organizational change effort. The model includes casual
elements, meaning that that these elements interact with and affect each other. The structure of
the model includes two dynamics that provide guidance for describing the macro and micro
levels of organization: culture and climate, respectively. Culture is defined as the organization
beliefs and values. Climate is defined in terms of how individuals perceive their local work unit
is managed and how they and their coworkers work together. Climate is influenced by the overall
culture of the organization.
The model distinguishes among the 12 elements by terming them transactional or
transformational variables. Transactional variables are affected by human behavior on the micro
level: everyday interactions and exchanges on the work unit such as the structure, management
practices, systems, work unit climate, task and individual skills, motivation, and individual needs
and values. Transformational variables are concerned with macro level organizational processes
and culture changes in behavior. Transformational variables interact with the environment,
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whether external or internal. These are the most influential in organizational change and include
external environment, mission and strategy, leadership, and organizational culture. Changes in
transformational processes are required to enact lasting change in an organization. While
transformational variables influence lasting change, transactional variables remain important and
should be assessed as both sets of variables interact and affect individual and organizational
performance.
Organizational Assessment
The managing physician in the preoperative assessment center (PAC), an interventional
cardiology registered nurse, and a clinical practice specialist for cardiothoracic surgery were
interviewed to obtain a deeper understanding of the transactional dynamics of the organization.
The external environment was a strong motivator to change practice and reduce blood usage due
to the scarcity of blood products, the potential for serious adverse effects, and the high cost of
blood products.
The mission and strategy, leadership, structure, work unit climate, individual abilities of
staff, and culture all served as facilitators for this practice change initiative. The mission of MHS
promotes quality improvement initiatives to “improve the health of communities…” that they
serve. The climate and leadership qualities in both the CTS and PAC offices are strong, positive,
and encourage change projects that will positively affect the patients. Each office is committed to
quality improvement and strives to exceed the national benchmarks for adult surgical outcomes.
An identified potential barrier was that this health system does not have an effective process in
place for ordering and managing IV infusions. This was addressed prior to implementing the
practice change.
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Ethics and Protection of Human Subjects
The Institutional Review Boards (see Appendix B and C) of the university and site
determined the project was quality improvement.
Stakeholders
A project cannot function properly without key stakeholders invested in the project
(Moran, Burson, & Conrad, 2017). Key stakeholders in this anemia management project
included healthcare providers (physicians, nurse practitioners, and physician assistants),
registered nurses, pharmacists, infusion clinic staff, quality improvement specialists, laboratory
technicians, outpatient cardiology office staff, and patients. Healthcare providers were included
as stakeholders as prescribers of blood, iron infusion products, and preoperative testing.
Pharmacists were included because they mix the iron infusion products and were instrumental in
creating the algorithm for proper anemia management. Other stakeholders that were identified
included infusion clinic personnel because they administer the infusion, laboratory technicians
because of the need to draw appropriate labs, and finally the patients who receive the blood
products or iron infusions. Outpatient cardiology office staff were instrumental in assisting the
DNP student with the project.
SWOT: Strengths, Weakness, Opportunities, and Threats
A SWOT analysis is a tool used to perform an assessment of an organization’s strengths,
weaknesses, opportunities, and threats (Moran, Burson, & Conrad, 2017). The evaluation of the
internal strengths and weaknesses, along with the evaluation of the external opportunities and
threats, provides a general overview of the current state of the organization. Strengths refer to the
internal traits that are helpful to a program, such as efficient processes, experienced staff, or an
aesthetically appealing environment (Moran, Burson, & Conrad, 2017). Weaknesses denote the
internal traits that are harmful to a program, such as underlying tension in the office or
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knowledge gaps. Opportunities are the external traits or changes that could help the program,
while threats refer to the external traits or changes that may be harmful. The strengths,
weaknesses, opportunities, and threats of the preoperative assessment center in a large MHS
were analyzed per discussions with key stakeholders; specifically, with the nursing practice
manager (see Appendix D).
The strengths of the PAC were identified and included motivated leaders and consistent,
expert providers in the realm of preoperative assessment, and a close relationship to the
connecting hospital. The PAC offers a comprehensive preoperative optimization visit with
enhanced quality of care by incorporating evidence-based practice measures. The PAC was
affiliated with a Magnet® designated health system, which is a distinction that honors nursing
excellence and high-quality patient care. The PAC also has opportunities. The PAC has
bandwidth for providers to see more patients to manage care prior to surgery. The PAC enjoys a
close relationship with its existing providers and anesthesiologists, which has resulted in
effective communication.
Weaknesses of the PAC included gaps in needed professions, such as a pharmacist to
oversee medication changes and dosing, dieticians to aid in lifestyle education and modification,
and a medical assistant to collect blood samples. Historically, MHS had not had a process in
place to order and manage IV infusions. This frustrated providers, which may be why IV
infusions were not done as frequently as needed.
Threats were also identified. CTS and the PAC did not have a working relationship,
which may have caused hesitancy to collaborate due to a lack of trust. As an organization, MHS
had not thus far encouraged preoperative anemia management, which may have caused some
push-back from stakeholders during process change. It is important to be aware of and address
these weaknesses and threats to lessen their effect on the practice change.
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Clinical Practice Question
The clinical practice question was: If patients are referred to a preoperative assessment
center prior to CABG surgery for preoperative anemia work-up, will the number of patients
undergoing CABG surgery with untreated anemia decrease?
Review of the Literature
To determine best practice for preoperative anemia management, a literature review was
conducted. The primary objective of the review was to identify detection and treatment of
preoperative anemia in CABG patients. Therefore, safe, effective, and evidence-based methods
to treat preoperative anemia were examined. The central theme of the review was iron infusion
and EPO administration prior to cardiothoracic surgery, as they are safe and cost-effective
alternatives to blood product use.
Methods
PRISMA. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guideline served as the framework for the review (Moher, Liberati, Tetzlaff, Altman,
& PRISMA Group, 2009). A comprehensive electronic search was conducted in the Google
Scholar, PubMed, and Cochrane Library databases. The search was limited to reviews in the
English language during the period of 2013 to 2018. Reference lists from the included studies
were reviewed to identify potential additional sources. Keywords included: anemia, preoperative
anemia, cardiac surgery, anemia management, cardiac, adult, iron infusion, and erythropoietin.
Results were filtered to only show systematic reviews, meta-analyses, and randomized control
trials.
Aim of the Review. This review answered four questions:
•

Does any formulation of iron supplementation therapy increase hemoglobin
concentration in anemic patients?
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What formulation of iron supplementation is safe and effective in improving hemoglobin
levels in anemic patients?

•

What formulation of iron supplementations reduces the risk of aRBCt in anemic patients?

•

Is EPO therapy safe and efficacious in reducing the use of aRBCt in cardiac surgery?

Inclusion and Exclusion Criteria
Article Types. Included in the literature review were randomized control trials (RCT),
systematic reviews, and meta-analyses. Excluded were studies less than an RCT.
Population. Included were samples that featured non-pregnant, anemic adults without
chronic kidney disease. Pediatric populations, adults with chronic kidney disease, emergency
surgeries, treatment refusal, and patients allergic to iron were excluded.
Intervention. Articles with multifactorial and single interventions were included in this
review. Articles that only reported study results without stating the mechanisms of the
intervention were excluded.
Comparison. Articles that included any type of iron preparation were included in this
review. Articles that compared single or multifactorial interventions with a placebo were
included in this review. Articles that used EPO as a single-dosed intervention or in conjunction
with iron supplementation were included. Articles that did not use either iron supplementation or
EPO therapy prior to surgery were excluded.
Outcome. Reviews that reported the outcome of an intervention on preoperative anemia
measured in one of, or in a combination of the following were included: change in hemoglobin
concentration pre- and post-intervention, morbidity and mortality, length of hospital stay, and
blood transfusion requirement. Studies that did not include at least one of these measures were
excluded.
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Search Outcomes
The search yielded 324 studies (see Appendix E). Twenty-two were retrieved from the
Cochrane Library, 241 from Google Scholar, and 61 from PubMed. Three articles were found
through review of reference lists of included studies. Seven duplicates were found. After
removing the duplicates, the titles and abstracts of 320 articles were screened. After reviewing
the titles and abstracts, 290 articles were excluded for reasons pertaining to population,
intervention, comparison, and outcome. Thirty full-text articles were assessed for eligibility
using inclusion and exclusion criteria according to PRISMA criteria (Moher et al., 2009).
Review of titles and abstracts resulted in removal of 22 articles that did not meet the inclusion
criteria; the remaining eight articles were included in this review.
Summary of Results
Eight articles met the inclusion criteria and were included (see Appendix F). Included in
this literature review were two Cochrane Reviews (Clevenger et al., 2016; Gurusamy et al.,
2014), two systematic reviews (Lin et al., 2013; Litton et al., 2013), three RCTs (Cladellas et al.,
2012; Weltert et al., 2015; Yoo et al., 2011), and one comprehensive review article (Peters et al.,
2018).
Project Evidence
The authors of these reviews found use of iron therapy and/or EPO to correct
preoperative anemia is safe and efficacious. The authors of four of eight reviews supported the
use of iron therapy, specifically IV iron to treat anemia (Clevenger et al., 2016; Gurusamy et al.,
2014; Litton et al., 2013; Peters et al., 2018). There was some evidence that oral iron is also
efficacious in treating anemia, but less so than IV iron (Clevenger et al., 2016; Gurusamy et al.,
2014; Lin et al., 2013). The authors of all articles measured a change in blood transfusion
requirements. The authors of three reviews described a decrease in the proportion of people who
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required blood transfusion after supplementation with both oral and IV iron compared with
inactive control (Clevenger et al., 2016; Gurusamy et al., 2014; Peters et al., 2018). Two of the
eight RCTs supported use of a single dose of EPO prior to cardiac surgery to reduce aRBCt
(Weltert et al., 2015; Yoo et al., 2011). Two of eight studies supported the use of EPO combined
with IV iron to reduce aRBCt (Cladellas et al., 2012; Lin et al., 2013).
The authors of three of the eight studies examined a decrease in overall mortality
(Cladellas et al., 2012; Clevenger et al., 2016; Weltert et al., 2015). Overall, serious adverse
events and mortality were not increased with the use of IV iron compared with oral or no iron or
with the use of EPO, whether as single therapy or in combination with IV iron infusion (Litton et
al., 2013; Yoo et al., 2011). It is important to note, however, that none of the studies included in
this review found increased mortality. One study found an increased risk of all-cause infection
associated with IV iron, but the authors admit that their result may have been a false positive and
inconclusive due to the lack of associated infection in IV iron in other settings (i.e. dialysis, postsurgical iron infusions) (Litton et al., 2013).
The authors of all eight studies cited that iron supplementation with or without the use of
EPO, or a single dose of EPO used separately, decreased the number of aRBCt per patient.
Correcting anemia prior to surgery may decrease the risk of blood transfusion associated adverse
events and shorten length of hospital stays (Cladellas et al., 2012; Clevenger et al., 2016).
Model to Examine Phenomenon
To help facilitate successful implementation and aid in sustaining the project, an
implementation model guided the project execution. Conceptual models help to identify elements
that are crucial to project success that may have otherwise been overlooked. The Promoting
Action on Research in Health Sciences (PARiHS) framework (Kitson, Harvey, & McCormack,
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1998) (see Appendix G) was used. The key elements of the PARiHS model are described in
relation to this DNP project.
PARiHS Model
Kitson et al. (1998) argue that successful integration of research into practice can be
defined by the interplay of three core elements: level of evidence, the context or environment
where research will be placed, and the facilitation process. Unlike other preceding theories on
research implementation, Kitson et al. (1998) stipulates that all three elements should have equal
standing. This model can be used as a checklist for users to assess needs prior to implementing
research into practice.
The central caveat of this model is derived from the following equation:
•

SI = f(E, C, F)
o Where SI = successful implementation, f = function of E = evidence, C = context,
and F = facilitation.

The premise of this model is that successful implementation is directly influenced by the
relationship between the strength and nature of the available evidence, the context of the change
environment, and the change mechanisms utilized. Kitson et al. (1998) suggests that all of these
dimensions be considered simultaneously rather than in a hierarchy.
Evidence. Kitson et al. (1998) defines evidence as a synthesis of research, clinical
expertise, and patient choice. Research quality may be low (anecdotal or descriptive) or high
(RCTs, systematic reviews, evidence-based guidelines). Clinical experience is rated on a
spectrum from high (consistent consensus) to low (divided opinion). Patient preference is rated
by either the lack of patient involvement in healthcare or a partnership between healthcare
providers and patients. For successful implementation of research that supports change, the
evidence needs to be high quality, high consensus, and have high patient input.
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The evidence for IV iron in the treatment of anemia has been established in multiple
systematic reviews and RCTs. Professional consensus on the adverse effects of blood
transfusions and alternate therapies to avoid transfusions is also well established (Cladellas et al.,
2012; Clevenger et al., 2016; dos Santos et al., 2013). Patient input was considered in this change
initiative. Providers are expected to educate and involve patients in the treatment plan and be
available for questions or concerns.
Context. Context is the venue where the change will be implemented (Kitson et al.,
1998). Context is subdivided into three components: an understanding of the setting’s culture,
the nature of relationships as seen through leadership roles, and how the organization measures
its systems. Each of these three components runs along a range of high to low context. Culture is
effective when the organization is patient-centered, appreciates employees, and values continued
learning. Higher leadership consists of clear roles, effective teamwork, and clear structure. High
context of measurement routinely utilizes internal and external performance measures.
As identified by the organizational assessment, there is a high level of context for this
project. This project had a buy-in from leaders in organization. According to public information
from the organization, a goal of MHS is to involve patients and families in their care and act with
integrity, respect, and compassion. This organization is a teaching hospital that is open to change
and ongoing learning. The proposed change project was welcomed at this organization. This
project directly affected the cardiothoracic surgery group in the organization. This group was
focused on quality measures and had well-attended, monthly meetings to discuss quality
initiatives and how to improve the care they provide to patients.
Facilitation. Facilitation describes the behavior and support that is required to help
people change their attitudes, skills, and ways of working (Kitson, et al., 1998). Successful
facilitators must have strong attributes in three categories: characteristics, roles, and style. To
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affect change, facilitators must be open, supportive, approachable, reliable, and have clarity
around the facilitator role. Facilitators bring a personal set of skills as well as an ability to work
within and across role boundaries in an organization (Kitson, et al., 1998). Even with high
quality evidence and a context that is receptive to change, implementation may fail under nonexistent or ineffective facilitation.
The DNP student acted as the facilitator in this change project. A barrier to facilitation
was identified during the needs assessment. This organization has an unclear process when
ordering infusions in the outpatient setting. After discussion with key stakeholders, it was clear
that the barrier may prove detrimental to the change intended within the project, if not addressed.
The DNP student conducted meetings with key stakeholders to discover solutions to the problem.
It was decided that a practice manager from the infusion center would provide education on how
to order an infusion and provide a tip sheet to the PAC. The infusion center practice manager
went to the PAC to educate providers in December 2018, prior to implementation. This manager
assured the PAC that the infusion centers had the ability to see more patients and that infusions
would be timely. Providers at the PAC expressed understanding of the process and found it to be
more convenient than previously thought. The DNP student remained a resource for providers
during the implementation process. To further assist in facilitation of this DNP project, the
student remained respectful and flexible during the course of this project. Addressing concerns
and being available is crucial during the beginning of and throughout the course of a change
project. Remaining empathetic to the interruption of the workflow and required effort during a
change in practice helped to foster trust between the facilitator and the healthcare providers.
Successful Implementation. Successful implementation occurs most often when
evidence is high, the context is ready for change, when feedback mechanisms in place, and when
there is facilitation (Kitson, et al., 1998). All three of these dimensions should be considered
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equally when implementing a practice change. As previously stated, the evidence for this DNP
project was high, consisting of systematic reviews and RCTs. An organizational assessment and
a SWOT analysis of the outpatient preoperative assessment center were conducted to better
understand the context and need for facilitation in the setting for this project.
Project Plan
Purpose of Project and Objectives
The purpose of this project was to implement an evidence-based practice improvement
initiative to improve the treatment of iron deficiency anemia prior to CABG surgery in a large
MHS. The objectives for this project included: (1) conducting an organizational assessment of
MHS to establish current state, (2) reviewing the literature to identify best-practice to treat irondeficiency anemia that has the potential to reduce blood products used in the perioperative
setting, and (3) restructuring the current process within the setting to improve identification and
treatment of iron deficiency anemia prior to cardiac surgery. This project sought to answer this
clinical question: If patients are referred to a preoperative assessment center prior to CABG
surgery for preoperative anemia work-up, will the number of patients entering CABG surgery
without anemia treatment decrease?
Design for the Evidence-based Initiative
This was a quality improvement project. The phenomenon was examined using the
PARiHS model. The initiative was based on the Kotter (1996) framework. The student
considered the three core elements of the PARiHS framework when designing the project.
Setting
Administrative approval to conduct the project at this facility was secured (see Appendix
H). The DNP student implemented the project at the PAC associated with MHS. The PAC
provides medical evaluation and optimization to assess risks prior to surgery. Typical
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preoperative medical evaluation of patients is highly variable. In contrast, the PAC offers a
standardized approach to preoperative medical evaluation and management to avoid preventable
complications and mortality. In the current state, the PAC cared for orthopedic, bariatric, and
vascular pre-surgical patients. There were four providers that service 3,800 patients a year;
approximately half of the potential capacity. The goal for the PAC was to see all surgical patients
in the health system in the next two to three years.
Participants
The project participants included the patients receiving the treatment for anemia and the
healthcare providers in both the PAC and CTS offices. The scheduler for CTS, a medical
assistant, were included to prep patient charts for surgeons prior to the initial consultation. The
CTS scheduler worked with the PAC scheduler, a nursing technician, in scheduling patient
appointments. The CTS surgeon performed the surgical consultation. The nurses in the CTS
office were included to schedule the actual surgery and to educate patients on preoperative
testing, if applicable. The healthcare providers in the PAC ordered the proper anemia treatment
for the patients.
Patients were identified for anemia treatment based on hemoglobin and mean corpuscular
volume (MCV) levels prior to cardiac catheterization. Anemia is defined as a hemoglobin
concentration of less than 12 g/dL in non-pregnant women and less than 13 g/dL in men (WHO,
2008). MCV is the average size of red cells in a specimen (Curry, 2015). The MCV determines if
an anemia is microcytic, normocytic, or macrocytic, as corrective therapy changes based on this
result (Curry, 2015). The nurses in the CTS office ordered additional blood work for anemic
patients based on their MCV from the blood work done pre-cardiac catheterization. The blood
work was done prior to the appointment at the PAC so that providers had that information prior,
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expediting the treatment process. Only anemic patients that were CABG candidates were
included in this pilot project.
Model Guiding Implementation
Kotter’s eight steps of change were used as a guiding framework to support this practice
change (see Appendix I). Kotter (1996) created the model after 40 years of observing
organizations as they were attempting to implement changes. There are three phases, which
include eight steps that are needed to successfully implement change in an organization. These
three phases include creating a climate for change, engaging and enabling the organization, and
implementing and sustaining for change (Kotter, 1996).
Creating climate for change. The first phase consists of the first three steps to help the
organization prepare for change. The first step is to establish a sense of urgency (Kotter, 1996).
This requires the facilitator to help others recognize the need for change through a bold statement
that inspires immediacy (Kotter International, 2018). The second step is to build a guiding
coalition (Kotter, 1996). This coalition is made of leaders and effective people to sponsor and
guide change (Kotter International, 2018). The third and final step in this first phase is to create a
vision for change (Kotter, 1996). This involves clarifying how the change will affect the future
and will guide people how to make the future a reality (Kotter International, 2018).
Engaging and enabling the organization. The second phase consists of the next three
steps to enable the organization to change through communication and generating momentum.
The fourth step is to communicate the vision (Kotter, 1996). Facilitators and leaders need to
communicate the change throughout the organization. Change champions may assist in this
effort (Kotter International, 2018). The fifth step is to empower action (Kotter, 1996). At this
step, barriers to success need to be addressed and removed to promote action among the team
members (Kotter International, 2017). The sixth step in the second phase is to create quick wins
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(Kotter, 1996). Achieving and celebrating short term goals motivates team members and allows
all to see that the change delivers results (Kotter International, 2018).
Implementing and sustaining for change. The third phase consists of the final two steps
in the change process. The seventh step is to build on the change (Kotter, 1996). At this point, it
is important not to let up as the first successes of the change are enacted in the organization.
These successes must be used to accelerate improvements of systems and policies (Kotter
International, 2018). The eighth and final step of the process is to “make it stick” (Kotter, 1996).
This happens by ensuring that the new changes are strong enough to replace old habits and by
ensuring that the new changes are integral to the success of the organization (Kotter
International, 2018).
Implementation Steps and Strategies
Implementation strategies for this project were selected based on the nature of the
proposed project and the principles of Kotter’s Change Model (1996). A compilation of
evidence-based strategies from Powell et al. (2015) was also used to guide the selection of
specific implementation steps.
1. Assess readiness and identify barriers and facilitators: When considering a potential
quality improvement project, it is imperative that the DNP student first took the time to
complete an organizational assessment (Moran, Burson, & Conrad, 2017). This enhanced
project implementation, organizational change, and determine the potential for
sustainability. This strategy guided the DNP student to assess various parts of the
organization to determine the degree of readiness to implement and to identify barriers
and strengths that may hinder or help the project succeed (Powell, et al., 2015).
•

From May through July 2018, the DNP student spent approximately 40 hours meeting
with nursing managers, clinical practice managers, lead registered nurses of
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outpatient clinics, and the CTS Renal and Blood Utilization Group. This helped the
DNP student gain an understanding of the current state of anemia management.
•

From May through July 2018, the DNP student spent approximately 20 hours
shadowing key stakeholders in their roles and holding meetings with appropriate
personnel to assess the organization for readiness and willingness to change.

•

In August 2018, the DNP student met with the PAC practice manager to perform a
SWOT analysis of the PAC. This included the internal strengths and weaknesses and
its external opportunities and threats.

2. Build a coalition/Identify early adopters: This strategy involves identifying and
recruiting early adopters and cultivating positive relationships with key stakeholders
(Kotter, 1996; Powell, et al., 2015).
•

From May to November 2018, the DNP student sought to build a positive relationship
with the clinical practice manager of cardiovascular medicine at MHS. The manager
is well connected and has introduced the student to key stakeholders.

•

In August 2018, the DNP student worked with the site mentor to recruit a small
subcommittee of volunteers from the CTS Renal and Blood Utilization Group to
assist in designing implementation strategies for the project. This small subcommittee
included the DNP student, the practice manager, a quality improvement specialist and
the quality manager for CTS. This group worked together to plan a process for
anemia management in CABG patients (see Appendix J).

•

On October 5, 2018, the DNP student shared the process for anemia management to
the subcommittee and with key stakeholders from CTS and the PAC. This included
the division chief of CTS, the medical director of the PAC, cardiovascular operations
director, the DNP student, quality improvement specialists, the clinical practice
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manager serving as the mentor to this project, and the director of surgical services.
This process included the approved algorithm for anemia management (see Appendix
K). The process change was introduced to CTS surgeons in late October and was
approved by this group. A meeting to operationalize the process took place in
November 2018 with the manager of CTS, the PAC manager, the DNP student and
the cardiovascular practice manager serving as a mentor.
3. Develop and distribute education materials/Conduct educational meetings:
Providing education materials allows stakeholders to learn about the new process and can
serve as a passive reminder tool during implementation (Powell, et al., 2015). This
includes holding meetings with stakeholders to teach them about the project (Powell, et
al., 2015).
•

In November 2018, the DNP student and key stakeholders met to discuss the best
strategies for provider education.

•

During the November 2018 CTS staff meeting, the DNP student and project mentor
presented the project to the stakeholders.

•

During December 2018, CTS and PAC received information on the new PAC referral
process and the anemia management order set. Information on workflow changes
were provided. A tip sheet was designed to assist CTS staff in placing a referral to
PAC and to assist in explaining the new process to patients (see Appendix L).

4. Conduct tests of change: This implementation strategy allows for small, cyclical tests
before change is trialed system-wide. The results of small tests can be used to gain insight
before implementing on a larger scale (Powell, et al., 2015).
•

The pilot project started in December 2018. As part of current state, patients receive
an order from the interventional cardiologist to have a complete blood count (CBC)
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and basic metabolic panel drawn within one week prior to arriving to the cath lab.
Patients were identified as surgical candidates by an interventional cardiology
physician during the cath lab procedure if the patient’s heart disease is too advanced
for cardiac stenting alone. Patients who were surgical candidates were then referred
for surgical consultation. The registered nurse in the cath lab contacted the CTS
scheduler who makes an appointment for the patient to see the cardiothoracic
surgeon.
•

In December 2018, the pilot project started with patients of one surgeon with a
CABG procedure. Another surgeon was added to the pilot for the last four weeks of
implementation. Using the new process change, the CTS scheduler prepped the
patient charts for the surgeons prior to the initial surgical consultation and identified
anemic patients using the CBC drawn prior to the cath lab procedure. If the patients
were anemic, the CTS scheduler collaborated with the PAC scheduler to make
tandem appointments for the patient to see the surgeon and a provider at the PAC on
the same day, when possible. The nurses in the CTS office then scheduled the surgery
following the initial surgical consultation appointment, provided pre-surgery
education for the patients, and then directed them to the PAC for their surgical
optimization appointment. The CTS registered nurses in the surgeon’s office also
ordered additional laboratory studies as indicated, including iron studies, vitamin B12
levels, and folate levels.

•

From December 2018 through February 2019, patients with anemia were sent to the
PAC for presurgical optimization. The nurse practitioners in the PAC ordered the
necessary treatment for the patient’s anemia. Referrals to the infusion center were
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made, if needed. The medical director and the nurse practitioners in PAC remained in
contact with the surgeon. PAC followed each patient until the date of surgery.
5. Audit and provide feedback/facilitate relay of clinical data to providers: This
encompasses distributing performance data to key stakeholders over a specific period.
This allows the student to provide feedback to providers, offers providers a tool for selfevaluation, and provides quick wins during the practice change (Kotter, 1996; Powell, et
al., 2015).
•

Key stakeholders received weekly progress reports on the project and updates on how
the practice change was progressing. This included how many patients were treated
per protocol, what they were treated with, and potential barriers that arose during
implementation, with possible solutions.

•

The DNP student sought feedback from providers regarding facilitators and barriers
identified during the project. Pre-implementation data were collected in November
2018 for the period of August through October 2018. Post- implementation data was
collected in March 2018 for the period of December 2018 to February 2019.

•

The DNP student collected measures using the STS data dashboard and through
individual chart audit.

6. Capture and share local knowledge: Disseminating the results of the DNP project is an
evidence-based strategy and can assist other organizations to improve their systems
(Powell, et al., 2015).
•

In March 2019, the DNP student shared final project results with key stakeholders.

•

CTS and PAC received a post-implementation satisfaction survey regarding provider
satisfaction with the process change. This clarified any added value of project
implementation and project sustainability (see Appendix M & N).
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In April 2019, the DNP student provided a final report to MHS outlining project
outcomes; and presented at the sites research council poster day on April 9, 2019.

•

In April 2019, the DNP student conducted final DNP project defense to disseminate
further goals, sustainability options, and results; and published in ScholarWorks©.

Measures
Measures are outlined below and shown in Appendix O:
•

Data were collected through chart audit included patient age, sex, presence of anemia
diagnosis, hemoglobin prior to cardiac catheterization, referral to the PAC, presence of
anemia treatment, type of anemia treatment, hemoglobin prior to surgery, presence of
blood product usage, type of blood products used, if any, and hemoglobin after surgery.

•

The DNP student collected data from chart audits and using a tool (see Appendix P).
Quality improvement specialists from cardiovascular services assisted the DNP student in
collecting STS quality data.

•

Provider satisfaction is integral to the continued success of a process change. A postimplementation survey regarding provider satisfaction with the process change was
distributed after implementation, assisted by the PAC and CTS practice managers, to
obtain information on project sustainability. CTS surgeons received a six-question survey
in Likert format. PAC nurse practitioners received a five-question survey in Likert
format. Both scales ranked answers from 1 “strongly disagree” to 5 “strongly agree” . In
total, there were four surveys distributed and four surveys that were completed and
returned. Each survey offered a comment section at the bottom.

•

The number of patients appropriately screened and treated per protocol for anemia prior
to CABG surgery were analyzed pre- and post-implementation by chart audit. This
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information identified whether the process change resulted in increased awareness of
anemia and treatment prior to CABG surgery.
•

Use of perioperative blood products were measured during implementation to assess
whether treatment of anemia resulted in a decrease in blood utilization. A comparison of
a random sample of 10 patients not included in the pilot project were compared to
patients in the pilot project. The DNP student obtained data from the MHS Blood
Utilization Dashboard and through chart audit.

•

A global change in hemoglobin was measured in two groups: the average hemoglobin in
10 patients not included in the pilot project were compared to patients in the pilot project.
The data was obtained through chart audits.

Data Collection Procedures
The DNP student collected data for the project from the electronic health record (EHR)
and STS quality data using a chart audit tool pre- and post-implementation in a Microsoft
EXCEL spreadsheet. The pre-implementation audit was done in November 2018 and included all
elective CABG surgeries from August 2018 through October 2018 (N = 54 surgeries). The postimplementation audit was done in March 2019 and included a random sample of 10 patients not
included in the pilot project and 14 patients in the pilot project, December 2018 through
February 2019. Satisfaction outcomes with the new process for preoperative management of
CABG patients was obtained by a Likert-style survey designed by the DNP student. The survey
was piloted for clarity, then distributed to CTS surgeons and PAC providers in March 2019 postimplementation with the assistance of the CTS practice manager.
Data Management
The DNP student was responsible for data management throughout this project. After
data collection was completed, the DNP student, in collaboration with a university statistician,
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transferred the de-identified data to SAS for analysis. Data was stored on MHS internal drive that
is only accessible by approved individuals (identified by health system administration). All
protected personal information was removed to protect patient identity. Data remained on the
drive upon completion of the project.
Analysis
The data was analyzed with support from a university statistician. The proportion of
patients entering surgery treated for anemia pre- and post-implementation were analyzed with a
one sample test of proportions. The amount of blood products used in the perioperative setting
pre- and post-implementation and average post-operative hemoglobin of CABG patients in the
pilot group and the random sample of non-pilot group patients was analyzed using Wilcox Rank
Sum test. Descriptive statistics were used to report satisfaction.
Resources & Budget
The budget for the project is shown in Appendix Q. Resources needed for this project
included the time and monetary compensation of key stakeholders and participants (Salary.com,
2019). Resources such as computers and an electronic health record were already available at the
organization. The main resource was compensation for time of stakeholders planning the project,
time of staff during education, and the cost of anemia treatment.
The DNP student and GVSU statistician donated time for the project. Potential cost
savings from this project include preventing the use of packed red blood cell transfusions in the
perioperative period. At $761 ± $294 per unit, packed red blood cells are costly and are also
potentially dangerous to patients (Shander et al., 2010). Packed red blood cells should not be first
line for anemia in the perioperative period due to the associated complications (dos Santos et al.,
2013; dos Santos, et al., 2014).
In a three-month period prior to the implementation of this project (August-October
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2018), the majority of blood products used in surgery at MHS were used by anemic patients. In
that three-month period, anemic patients in CABG surgery used 31 units of packed red blood
cells while non-anemic patients used 17 units in that same period. The additional 14 units of
aRBCt cost $10,654 (Shander et al., 2010). Any change in procedure that could reduce the use of
packed red blood cells in surgery has proven to be potentially cost-saving and have a positive
impact on patient outcomes (Cladellas et al., 2012; Litton et al., 2013; Weltert et al., 2015; Yoo
et al., 2011).
Timeline
To ensure that the objectives of the project were met, Kotter’s eight-step change process
(1996) served as a guide. See Appendix R for the proposed timeline.
1. Establish sense of urgency: In September 2018, meetings with key stakeholders
began. The DNP student met with clinical practice manager of cardiovascular
medicine, quality improvement staff, and cardiothoracic surgery staff several times
between September and October 2018 to begin planning the project.
2. Build a guiding coalition: The DNP student identified additional key stakeholders in
the PAC and within the cardiothoracic surgery office in September 2018. The PAC
agreed to manage preoperative anemia with the surgeons.
3. Create a vision for change: On October 5, 2018, a vision was created by the DNP
student and clinical practice manager that defined the goals for the project.
4. Communicate the vision: In October 2018, the process for managing anemia in
CABG patients was presented to key stakeholders. The leaders of the surgical team of
the PAC agreed to begin a pilot project on preoperative management in CABG
patients. The finalized, proposed process was disseminated to the PAC,
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cardiothoracic surgical office staff, providers, and interventional cardiologists.
Education for these services was done in November and December 2018.
5. Empower action: The new process for anemia management was incorporated into
standard practice of one surgeon’s CABG-only patients by December 2018.
6. Create quick wins: Weekly updates on the progress of the anemia management were
disseminated via email to cardiothoracic surgery and to the PAC. Reinforcement of
the new process was provided throughout this timeframe via site visits, emails, and
dissemination at monthly quality meetings.
7. Build on the change: Weekly progress reports continued throughout the
implementation. A final review was provided for stakeholders by March 15, 2019.
The anemia management process remained in place as standard work. The final
review was presented to the CTS Quality Subcommittee in April 2019.
8. Make it stick: The anemia management process was expanded into other
cardiothoracic procedures and other surgeons.
Results
Twenty four patients divided into an intervention (n=14) and usual care (n=10) group
were analyzed. The intervention group were 14 patients that were screened using the new referral
process. The usual care group was a convenience sample of 10 patients that were not involved in
the new referral process. The average age of Intervention group was 63.8 (Standard Deviation
9.8 [SD]) years and 68.8 (SD 9.7) years in the usual care group. The intervention group were
21.4% (3 of 14) female and usual care were 10% (1 of 10) female.
Patients Screened for Anemia
CABG patients of one CTS surgeon were screened for anemia for all 12 weeks of
implementation using the new referral process. Another surgeon’s CABG patients were trialed

PREOPERATIVE ANEMIA MANAGEMENT

33

for the last four weeks of implementation. Of those in the intervention, 42.9% (6 of 14) were
anemic at the initial CTS consultation. Of those with anemia 83.3% (5 of 6) patients were
properly screened and referred to the PAC where they were evaluated. The one remaining patient
was not identified and was not referred and did not receive treatment for anemia prior to surgery.
Incidentally, this patient was no longer anemic at the time of surgery. Of the 20% (1 of 5) of the
patients referred to the PAC did not receive treatment for anemia as the patient’s hemoglobin
levels were considered to be baseline normal for that particular patient and care was
subsequently individualized.
In total, 66.6% (4 of 6) patients who were anemic, were identified and treated compared
to only 17% (7 of 41) of anemic outpatient CABG patients who were identified as anemic prior
to surgery in the pre-implementation (D’Agostino et al., 2018). Following implementation, the
proportion of patients f treated for anemia were statistically greater than pre-implementation
(p=.0006). Overall, there was a 49.6% increase in anemic patients receiving treatment prior to
surgery when pre- post-implementation were compared (see Appendix S). Incidentally, one
patient in the intervention group who was not anemic was prescribed EPO injections
preoperatively due to an inability to receive blood products during surgery.
Use of Perioperative Blood Products
The median blood products used in the intervention group were 1.5 units compared to 2
units in the usual care group. In the intervention group 42.9% (6 of 14) received blood products,
or 14 units of aRBCt. One unit of platelets was also used in Intervention group. Compared to
usual care, where 50% (5 of 10) received blood products, or 6 units of aRBCt. Other types of
blood products used include platelets (3 units) and cryoprecipitate (1 unit). While the
intervention group used more units of aRBCt, a higher proportion of patients who had usual care
received blood products. It should be noted that one patient received seven units of aRBCt in
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thee intervention group, skewing the data. After completing within and between analysis, 50% (5
of 10) of the intervention group received blood compared to 42.9% (6 of 14) in the group that did
not receive the intervention (p-Value = 1), showing no significant difference. Blood usage data is
shown in Appendix S.
Change in Hemoglobin
The intervention group had 42.9% (6 of 14) who were anemic at the time of their first
CTS surgical consult. One anemic patient was not referred nor treated, but was no longer anemic
in the perioperative period, leaving 35.7% (5 of 14) anemic at the time of surgery. In the usual
care group 20% (2 of 10) patients were anemic at time of their first CTS surgical consult. One
patient that was not anemic at the time of the initial consult became anemic in the perioperative
period, increasing to 30% (3 of 10) at the time of surgery.
The total average post-operative hemoglobin of all patients in the intervention group was
10.3 g/dL compared to 10.1 g/dL in the usual care group. There is not sufficient evidence to say
that the distribution of post-surgical hemoglobin differs between the groups were significant
(p=0.62). In the anemic patients, the total average post-operative hemoglobin in the intervention
group was 9.27 g/dL compared to 10.0 g/dL in the usual care group.
Provider Satisfaction: Survey Results
Two CTS surgeons and 2 nurse practitioners at the PAC that were involved in the pilot
project received the post-implementation survey (see Appendix M and N). The surveys for the
CTS surgeons and PAC nurse practitioners are discussed separately below.
CTS Survey. This survey consisted of six questions. Both surgeons answered neutral or
favorably to four questions. The second question “The referral process between the PAC and
CTS was easy to navigate” was answered with a “5” from Surgeon 1 and a “2” from Surgeon 2.
The fifth question “The communication between the PAC and CTS has met my expectations”
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was answered with a “2” from Surgeon 1 and a “3” from Surgeon 2. Five questions were
answered with a neutral or above-neutral average. The fifth question had an average Likert scale
answer of 2.5, below neutral. The sixth question of this survey was related to sustainability.
When asked, “,” both surgeons answered a “4,” or “Agree.” The graphic depiction of survey
responses for CTS Surgeons can be found in Appendix T.
PAC Survey. This survey consisted of five questions. Both providers answered neutral or
favorably to four questions. The first question, “This process change had no impact on my
workflow” was answered with a “3” from Provider 1 and a “2” from Provider 2. The average
answer of four questions was neutral or above-neutral. The first question had an average Likert
scale answer of 2.5, below neutral. The last question related to the sustainability of this referral
process. When asked, “I recognize the benefit of this referral process and am likely to continue to
support it,” both providers answered “4” or “Agree.” Provider 2 offered these comments on their
survey: "It took about [three] days with the last order for IV iron – "pending approval" before it
turned to authorized and patient was contacted. Also patient referred within [two] weeks of
surgery, so was only going to get [one] infusion [of IV iron]." The graphic depiction of survey
responses for PAC providers can be found in Appendix T.
Discussion
The results suggest that the new process increased awareness of preoperative anemia and
treatment with 50% of patients receiving care as expected. Four of the six patients who were
identified as anemic were treated prior to surgery, at a rate of 66.6%. This is a statistically
significant increase from the pre-implementation rate of 17% (p=.0006); in the preimplementation period, only one of the six identified anemic patients (17%) would have been
treated. Based on the results of the time limited project and the small pool of patients, this new
referral process increased awareness of anemia treatment and decreased the number of anemic
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patients who entered CABG surgery without anemia treatment, thereby improving the quality of
patient care. This is similar to findings of the others (Edwards & Slawski, 2016).
Blood product usage was increased in our intervention group; however, it was noted that
one patient in Intervention group used seven units of aRBCt and this may have skewed the data
for. Excluding this patient, Intervention group used six units of aRBCt and Group 2 used five
units of aRBCt. When examining the proportion of patients who used blood products, however, a
smaller proportion of patients in Intervention group (42.9%; n=6) received any type of blood
product while a larger proportion of Group 2 (50%; n=5) received blood products. This may be
due to an increased awareness of the cost of aRBCt; in dollars, and in patient outcomes
(Cladellas et al., 2012).
The average post-surgical hemoglobin of intervention group (10.3 g/dL) was higher than
that of the usual care group (10.1 g/dL). This is not statistically significant, but it is clinically
meaningful (p=0.6227). The intervention group had a higher average post-operative hemoglobin
than the usual care group, even though more patients that were anemic (42.86% versus 20%).
There may be other factors that contributed to this, but it may be that treating anemia prior to
surgery could have had a positive effect on the post-operative hemoglobin in intervention group.
This slight rise in hemoglobin in the intervention group, despite the higher number of anemic
patients, is one reason to continue the referral process that results in more patients being treated
for anemia.
Several colleagues recommended iron-deficient patients be treated with IV iron infusions
prior to surgery to improve hemoglobin recovery after surgery and to reduce the risk of aRBCt in
the perioperative period (Clevenger et al., 2016; Lin et al., 2013; Litton et al., 2013). In this
project, two of the four patients were treated with IV iron. The other two patients were treated
with oral iron supplementation. Oral iron has been shown to increase hemoglobin concentration,
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but not as well as IV iron infusions (Clevenger, et al., 2016; Gurusamy et al., 2014; Litton et al.,
2013). Had all applicable patients in Intervention group been treated with IV iron, it is possible
that post-surgical hemoglobin and blood product usage may have more noticeably changed.
In order to determine if iron infusions are successful in increasing hemoglobin, iron
levels are drawn one month following the last iron infusion. This information was not available
in most cases in this project. One patient that received iron infusions prior to surgery had a
longer wait time between the last iron infusion and surgery than average (three weeks for this
pilot project). This patient’s time between the last iron infusion and surgery was six weeks. In
that time, the patient’s pre-iron infusion hemoglobin of 9.1 g/dL rose to 11.4 g/dL just prior to
surgery. This robust hemoglobin change is consistent with findings from the literature
(Clevenger et al., 2016; Gurusamy et al., 2014; Litton et al., 2013; Peters et al., 2018).
Post-implementation surveys were distributed to clarify sustainability and added value of
this new referral process. In general, the satisfaction surveys were answered favorably, but some
concerns were noted. One provider at the PAC stated that the process changed work flow. The
provider was not specific on how the process changed their work flow and if this change was
negative or positive. Both PAC providers expressed some trepidation regarding the ease of
ordering iron infusions in the EHR. They found that the insurers were slow to authorize the iron
infusions and that patients were not always contacted in a timely manner for an appointment by
the infusion center, resulting in delayed patient care. However, all four providers were willing to
continue with the new referral process and answered favorably regarding added value.
Notably, ease of the referral process responses were disparate for both CTS and PAC.
Navigating the referral process proved difficult for one surgeon and communication between the
two offices lacked efficiency for the other surgeon. One surgeon found the process very easy and
the other surgeon found it difficult. The surgeon who found the process difficult was only
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involved in the process for four weeks, rather than the entire implementation period, which may
have contributed to this rating. Similarly, the provider at the PAC who found the referral process
easier than their counterpart was involved for a longer period of time in the project. These
responses suggest a correlation between the time involved in the process and the perception of
ease for the new referral process.
There were some differences noted between the original, proposed budget and the actual
final budget. The original budget noted a potential savings of $10,654, based on data available
for the three months prior to implementation. In that three-month period, anemic patients in
CABG surgery used 31 units of packed red blood cells while non-anemic patients used 17 units
in that same period. These numbers include surgeries performed by all CTS surgeons at MHS.
The additional 14 units of aRBCt cost $10,654 (D’Agostino et al., 2018; Shander et al., 2010).
Anemic patients, predictably, used more blood products than do non-anemic patients in
the three-month period prior to this implementation. This project also had a smaller sample size.
This is mostly due in part because there are fewer CTS surgeons involved than originally
anticipated. Seven surgeons were originally predicted to be involved. The management at CTS
elected to start this project with only two surgeons, rather than seven. So two surgeons’ patients
were ultimately included in the pilot. Achieving a cost savings of over $10,000 is not feasible
when the actual sample size is so much smaller than the predicted size. In this small pilot project,
there was not a significant change in blood usage between the intervention group and usual care.
There was a potential for cost-savings as originally predicted; however, one patient in the
intervention group used seven units of aRBCt, which skewed the data. This project did not
investigate any other cost saving measures, such as length of stay. Evidence has shown that
correcting anemia to reduce use of aRBCt will positively affect the length of stay (Cladellas et
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al., 2012; Clevenger et al., 2016). Further investigations into how anemia can adversely affect
length of stay for CABG patients are needed in the future.
An unintended positive consequence of this project was that patients were referred to a
preoperative assessment center that specialized in pre-surgical optimization of chronic diseases.
The patients that were referred also received close assessment of their other chronic diseases,
which may have resulted in better optimization on the whole. The screening and treatment of
preoperative anemia in CABG surgery increased due to the relationship between CTS and PAC.
The results of post-implementation provider surveys indicate that this process is sustainable.
Limitations
Limitations of this project include the following. This project had a short implementation
period and also had to function within the constraints of the organization. The organization
required that this project start with only one surgeon’s CABG-only patients, rather than trialing
the entire group of cardiothoracic surgeons. This resulted in a small sample size. The sample size
made it difficult to evaluate statistical significance.
During the implementation period, the staff member who prepped the charts for CTS
went on leave, requiring another staff member to take over the duties of that position as well as
their own. The staff member that went on leave was involved in the pilot project from the
beginning and was invested. The new staff member was not as involved and was not as invested.
This resulted in patient’s receiving a delayed referral to the PAC and a postponement of required
treatment for anemia. Even though the DNP student was present in the CTS office to assist, there
remained one patient referral fallout. Efforts to minimize limitations included close facilitation
by the DNP student in both the CTS and PAC offices. Weekly email updates were used to
energize staff on the status of the project and to celebrate successes.
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Examining the data, one patient alone received seven units of aRBCt in Intervention
group. That patient acts as an outlier and skews the data for Intervention group, making analysis
difficult. Post-operative hemoglobin was measured immediately after surgery. Per the anemia
algorithm in Appendix K, hemoglobin levels will show change after approximately one month
after the completion of iron therapy, however, this data was not available for this project.
Perioperative blood loss per patient was not collected. This information may have
provided insight on the relationship between blood loss and blood product usage. It may have
shown a correlation to what degree of perioperative blood loss is related to the transfusion of
blood products. It is noted that in a study that measured blood loss in 200 patients, average blood
loss in CABG surgery was around 500 milliliters (Bjessmo & Ivert, 2000).
Finally, nurses and support staff in the CTS office were not surveyed, making the survey
information incomplete. This information may have provided a more complete look at how the
new process was perceived.
Sustainability Plan
The results of this project were presented to the CTS Quality Subcommittee in their
monthly meeting in April 2019. Key stakeholders within the organization and in cardiothoracic
surgery have discussed further applications of this project model in different cardiac surgeries
and in conjunction with the PAC. After a discussion with CTS and PAC leaders, the referral
process will remain in place after the completion of this project. There is buy-in by key
stakeholders. The high involvement and buy-in from leadership and the quality of evidence are
strong indicators that this project is sustainable. There is also a possibility of a future DNP
student continuing this work with other surgical teams to assist in the implementation of a more
congruent preoperative optimization.
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Dissemination of Results
Dissemination of results occurred with key stakeholders of CTS on April 10, 2019 at
MHS. The final results were also shared with providers, the medical director, and the nursing
manager at the PAC. The final product of this project was presented at the university in front of
the DNP student’s advisory team and other members of the community who chose to attend on
April 15, 2019. The final draft of the project paper was uploaded to ScholarWorks© and can be
accessed by any interested party. This project was presented at MHS at an open forum poster
showcase in April 2019. The DNP student was available for organization leaders and community
members to answer questions and to explain the scope of the project.
Implications for Practice and Further Study in the Field
This project has multiple implications. Preoperative anemia can, and should, be treated.
Evidence suggests that treating preoperative anemia can positively impact patient outcomes and
is a cost-effective alternative to aRBCt in the perioperative period (Clevenger et al., 2016;
Gurusamy et al., 2014; Litton et al., 2013; Peters et al., 2018; Shander et al., 2010). Evidence
from this project also suggests that referring patients to the PAC can have a positive impact on
anemia management.
Referring patients to the PAC proved to be a success in the treatment of iron deficiency
anemia. Anemia that would otherwise have not been recognized was treated prior to surgery.
Continuing to refer patients to the PAC will result in continued treated of anemia and will also
involve close follow-up on other chronic conditions that may affect surgical outcomes. The PAC
staff have a close relationship with many surgical entities in MHS and CTS patients can benefit
from their expertise. The relationship between the PAC and CTS to treat anemia is not a static
affiliation, but something that will need to be continuously managed.
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Conclusion
Treating preoperative anemia in the CTS population is a focus of the CTS group at MHS.
An organizational assessment revealed that preoperative anemia is prevalent in about 30% of all
CTS patients at MHS. Preoperative anemia is currently undertreated at this organization resulting
in increased use of aRBCt, which can result in negative outcomes after surgery. A literature
review of treatment for preoperative anemia was conducted to identify best-practice
interventions for the treatment of anemia for use at MHS. Evidence revealed that treating anemia
prior to cardiac surgery can reduce the use of aRBCt in the perioperative period and lead to a
decrease in mortality (Cladellas et al., 2012; Clevenger et al., 2016; Weltert et al., 2015). CTS
partnered with a preoperative assessment center optimize comorbid conditions prior to surgery
and to treat preoperative anemia in CABG patients. One CTS surgeon was asked to refer his
anemic patients to the PAC for treatment and surgical optimization. This one surgeon referred
his anemic, elective CABG patients for a full twelve weeks. Another CTS surgeon was added to
the pilot for the last four weeks of implementation. Implementation resulted in five patients
being referred and treated for anemia.
Results revealed a statistically significant increase in the number of patients who were
treated for anemia prior to CABG surgery. There was no change in blood product use, but data
did reveal a lower proportion of patients who used blood products in the pilot group. This may be
interpreted as an increased awareness of the cost of aRBCt, not only in dollars, and improving
the quality of patient care. There was a clinically significant rise in post-operative hemoglobin
between the pilot group and the random sample of patients. This result was not statistically
significant, but it could be said that increased awareness and treatment of anemia prior to surgery
may have had a positive effect on the post-operative hemoglobin in the pilot group. The surveys
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for both CTS and PAC showed that all providers were willing to continue to support the new
referral process for treating anemia in outpatient CABG patients.
The potential cost savings to patient quality of life by avoiding perioperative adverse
effects relating to anemia and the cost of a unit of blood ($761 ± $294 per unit) are also
important factors to consider (Shander et al., 2010). The referral of these patients to the PAC for
their anemia also resulted in increased surveillance of their comorbid health conditions in the
perioperative period. The treatment of anemia prior to surgery is best practice and evidence has
shown that it improves outcomes after surgery.
Reflection on DNP Essentials
The American Association of Colleges of Nursing (AACN) requires that all DNP
students be proficient in the eight foundational competencies for advanced practice registered
nurses (AACN, 2006). Each essential was met throughout the development, implementation, and
dissemination of this DNP project and is reviewed below.
Essential I: Scientific Underpinnings for Practice
Addressing current and future practice issues requires a strong scientific educational
foundation. DNP graduates are prepared with a wide array of knowledge that is gleaned from
social and natural sciences. DNP graduates have the ability to translate that knowledge quickly
and effectively (AACN, 2006). This essential was achieved through this project in a number of
ways. In the course of this project, the DNP student performed a literature review on anemia and
best practice for treatment of perioperative anemia and applied those findings to a quality
improvement project. Knowledge of the organizational problem related to the management of
anemia in patients scheduled for CABG surgery was gleaned from clinical experts in the
organization. Clinical experts were consulted through personal meetings. In addition, the
PARiHS framework guided the implementation of the referral process to treat anemia. This
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framework focuses on evidence, context, and facilitation (Kitson, et al., 1998).
Essential II: Organizational and Systems Leadership
Organizational and systems leadership skills are critical for DNP graduates to improve
patient and healthcare outcomes. Doctoral level knowledge and skills in these areas contribute to
the effort to eliminate healthcare disparities and to promote excellence in practice (AACN,
2006). The DNP student demonstrated organizational leadership by first meeting with leadership
and performing an organizational needs assessment. This allowed the student to create a project
that best met the organization’s needs. The DNP student used communication skills learned from
the DNP program to lead this quality improvement initiative and negotiate the change process
and gain buy-in from key stakeholders. This project addressed the need to treat perioperative
anemia before cardiac surgery. Communication with leadership at both the PAC and CTS
occurred frequently and through the use of email, conference calls, and in-person meetings.
Budgetary issues and health policy discussions occurred frequently with the cardiovascular
medicine manager, the CTS manger, and with the CTS clinical program specialist. Costs for
patients and for the organization were discussed during project formulation as well.
Essential III: Clinical Scholarship and Analytical Methods
Research is a hallmark of doctoral education, but this essential focuses on the application
of research into practice and the dissemination and incorporation of new knowledge. These are
key attributes of the DNP graduates (AACN, 2006). Nursing exemplifies the relationship
between research application, science, and human needs. This quality improvement pilot project
was aimed at increasing anemia management in the cardiac surgical population as per best
practice guidelines. This new referral process will help to improve treatment of anemia in the
practice setting.
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Essential IV: Information Systems/Technology
DNP graduates are able to use their abilities as leaders to use information technology to
support and improve patient and healthcare system outcomes (AACN, 2006). DNP prepared
nurses can use information systems to evaluate outcomes of care, care systems, and programs
within the systems. Technology offers a way to apply budget and productivity tools, support
decision, and foster learning to improve the care of patients (AACN, 2006). A quality dashboard
to monitor blood usage at MHS was used frequently to inform the DNP student of any change in
blood usage through the course of this pilot. Information technology was used as a tool to collect
data throughout project implementation.
Essential V: Advocacy in Health Care Policy
Policy, whether it be organizational or in the government, provide a framework to
facilitate the delivery of healthcare services. DNPs need to be engaged in healthcare advocacy to
have a voice in policies that will affect the workplace and the patients that are served (AACN,
2006). Activism and commitment to policy development are central caveats to professional
nursing practice and the DNP has an ability to be a leader in advocacy (AACN, 2006). During
the course of the project, the DNP student took into account standard practice at the CTS office
and the general policies and procedures of the organization as a whole. While this project did not
involve any policy change, the goal was to move practice towards best practice for anemia
treatment according to existing guidelines.
Essential VI: Interprofessional Collaboration
The healthcare environment of today requires contributions from individuals in multiple
different professions. In order to accomplish safe, equitable, effective, and efficient patient care,
healthcare professionals must function as a team. DNP graduates are prepared to lead and
collaborate with different professionals in a complex environment to achieve goals (AACN,
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2006). The DNP student collaborated with many different disciplines in the CTS office, the
PAC, and in cardiovascular medicine throughout the course of this project. Different disciplines
that are integral to the progress of this project included surgeons, nurses, nursing managers,
quality improvement specialists, pharmacists, statisticians, and faculty members. The student
worked closely with providers at both the PAC and CTS to provide education during
implementation and to answer questions.
Essential VII: Clinical Prevention Population Health
DNP graduates are prepared to engage in leadership to integrate evidence-based clinical
prevention and population health services for individuals and the whole population. The DNP is
prepared to promote clinical prevention to individual patients and is prepared with a foundation
in population health (AACN, 2006). Concepts of public health concerns, health promotion, social
determinants of health, and promoting cultural diversity guide the practice of the DNP (AACN,
2006). The student evaluated specific organization data related to the anemia status of CABG
patients at MHS. This project was geared to improve the health status of patients in this specific
population. The environmental and cultural needs of the organization and this group of patients
were considered in the formulation of this pilot project.
Essential VIII: Advanced Nursing Practice
Due to the growth in specialization in the nursing field, no individual can master all
advanced roles and the required knowledge for enacting these roles. DNP programs provide
preparation within distinct specialties and mastery in one area (AACN, 2006). A DNP graduate
is prepared to practice in and have mastery in one area of specialization; this is the hallmark of
the DNP (AACN, 2006). DNP programs provide learning experiences that are based in a variety
of patient care settings and are integrated throughout the whole program. These learning
experiences help to inform future practice decisions. The student developed many partnerships
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during the course of this project. These partnerships exist between the DNP student and members
of the organization as well as between two entities at MHS, the PAC and CTS. The DNP student
was integral to the beginning of and the continuation of this relationship. The DNP student was
available for questions and to facilitate other staff members in this implementation period that
resulted in positive change for preoperative anemia management for elective CABG patients at
MHS.

PREOPERATIVE ANEMIA MANAGEMENT

48

References
American Association of Colleges of Nursing. (2006). The essentials of doctoral education for
advanced nursing practice. Retrieved from http://www.aacn.nche.edu/dnp/Essentials.pdf
Bjessmo, S. & Ivert, T. (2000). Blood loss after coronary artery bypass graft surgery: Relations
to patient variables and antithrombotic treatment. Scandinavian Cardiovascular Journal,
3(4), 438-45.
Burke, W. W., & Litwin, G. H. (1992). A causal model of organizational performance and
change. Journal of Management, 18(3), 523-545. doi:10.1177/014920639201800306
Cladellas, M., Farré, N., Comín-Colet, J., Gómez, M., Meroño, O., Bosch, M. A., … Bruguera, J.
(2012). Effects of preoperative intravenous erythropoietin plus iron on outcome in
anemic patients after cardiac valve replacement. American Journal of Cardiology,
110(7), 1021–1026. https://doi.org/10.1016/j.amjcard.2012.05.036
Clevenger, B., Gurusamy, K., Klein, A. A., Murphy, G. J., Anker, S. D., & Richards, T. (2016).
Systematic review and meta-analysis of iron therapy in anaemic adults without chronic
kidney disease: Updated and abridged Cochrane review. European Journal of Heart
Failure, 18(7), 774–785. https://doi.org/10.1002/ejhf.514
Curry, C.V. (2015). Mean corpuscular volume. Medscape. Retrieved from
https://emedicine.medscape.com/article/2085770-overview
D’Agostino, R. S., Jacobs, J. P., Badhwar, V., Fernandez, F. G., Paone, G., Wormuth, D. W., &
Shahian, D. M. (2018). The Society of Thoracic Surgeons adult cardiac surgery database:
2018 update on outcomes and quality. The Annals of Thoracic Surgery, 105(1), 15–23.
https://doi.org/10.1016/j.athoracsur.2017.10.035
dos Santos, A. A., Sousa, A. G., Thomé, H. O. de S., Machado, R. L., & Piotto, R. F.

PREOPERATIVE ANEMIA MANAGEMENT

49

(2013). Impact on early and late mortality after blood transfusion in coronary artery
bypass graft surgery. Revista Brasileira De Cirurgia Cardiovascular: Orgao Oficial Da
Sociedade Brasileira De Cirurgia Cardiovascular, 28(1), 1–9.
https://doi.org/10.5935/1678-9741.20130003
dos Santos, A. A., da Silva, J. P., da Silva, L. da F., de Sousa, A. G., Piotto, R. F., & Baumgratz,
J. F. (2014). Therapeutic options to minimize allogeneic blood transfusions and their
adverse effects in cardiac surgery: A systematic review. Revista Brasileira de Cirurgia
Cardiovascular: Órgão Oficial Da Sociedade Brasoleira de Cirurgia Cardiovascular,
29(4), 606–621. https://doi.org/10.5935/1678-9741.20140114
Edwards, A. F., & Slawski, B. (2016). Preoperative clinics. Anesthesiology Clinics, 34(1), 1–15.
https://doi.org/10.1016/j.anclin.2015.10.002
Gurusamy, K. S., Nagendran, M., Broadhurst, J. F., Anker, S. D., & Richards, T. (2014). Iron
therapy in anaemic adults without chronic kidney disease. The Cochrane Library. John
Wiley & Sons, Ltd. https://doi.org/10.1002/14651858.CD010640.pub2
Hung, M., Besser, M., Sharples, L. D., Nair, S. K., & Klein, A. A. (2011). The prevalence and
association with transfusion, intensive care unit stay and mortality of pre-operative
anaemia in a cohort of cardiac surgery patients. Anaesthesia, 66(9), 812–818.
https://doi.org/10.1111/j.1365-2044.2011.06819.x
Karkouti K., Wijeysundera D. N., & Beattie W. S. (2008). Risk associated with preoperative
anemia in cardiac surgery. Circulation, 117(4), 478–484.
https://doi.org/10.1161/CIRCULATIONAHA.107.718353
Kitson, A., Harvey, G., & McCormack, B. (1998). Enabling the implementation of evidence
based practice: A conceptual framework. Quality in Health Care, 7, 149-158.
doi:10.1136/qshc.7.3.149.

PREOPERATIVE ANEMIA MANAGEMENT

50

Kotter International. (2018). 8-step process. Retrieved from
https://www.kotterinternational.com/8-steps-process-for-leading-change/
Kotter, J. P. (1996). Why transformation efforts fail. The Journal of Product Innovation
Management, 13(2), 170.
Lin, D. M., Lin, E. S., & Tran, M.-H. (2013). Efficacy and safety of erythropoietin and
intravenous iron in perioperative blood management: A systematic review. Transfusion
Medicine Reviews, 27(4), 221–234. https://doi.org/10.1016/j.tmrv.2013.09.001
Litton, E., Xiao, J., & Ho, K. M. (2013). Safety and efficacy of intravenous iron therapy in
reducing requirement for allogeneic blood transfusion: Systematic review and metaanalysis of randomised clinical trials. The BMJ (Clinical Research Ed.), 347, f4822.
Moher D., Liberati, A., Tetzlaff, J., Altman, D.G., The PRISMA Group. (2009). Preferred
reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS
Med, 6(7): e1000097. doi:org/10.1371/journal.pmed.1000097
Moran, K., Burson, R., & Conrad, D. (2017). The doctor of nursing practice scholarly project: A
framework for success. (2nd ed.). Burlington, MA: Jones & Bartlett Learning.
Peters, F., Ellermann, I., & Steinbicker, A. U. (2018). Intravenous iron for treatment of anemia in
the 3 perisurgical phases: A review and analysis of the current literature. Anesthesia &
Analgesia, 126(4), 1268–1282. https://doi.org/10.1213/ANE.0000000000002591
Powell, B.J., Waltz, T.J., Chinman, M.J., Damschroder, L.J., Smith, J.L., Matthieu,
M.M….Kirchner, J.E. (2015). A refined compilation of implementation strategies:
Results from the Expert Recommendations for Implementing Change (ERIC) project.
Implementation Science, 10, 1-14. doi:10.1186/s13012-015-0209-1
Salary.com. (2019). Salary comparisons. Retrieved from https://swz.salary.com/SalaryWizard/
Shander, A., Hofmann, A., Ozawa, S., Theusinger, O. M., Gombotz, H., & Spahn, D. R. (2010).

PREOPERATIVE ANEMIA MANAGEMENT

51

Activity-based costs of blood transfusions in surgical patients at four hospitals.
Transfusion, 50(4), 753–765. https://doi.org/10.1111/j.1537-2995.2009.02518.x
The American National Red Cross. (2018). Critical Red Cross blood shortage prompts
emergency call for donations. American Red Cross. Retrieved from
https://www.redcrossblood.org/local-homepage/news/article/critical-red-cross-bloodshortage-prompts-emergency-call-for-donations.html
Weltert, L., Rondinelli, B., Bello, R., Falco, M., Bellisario, A., Maselli, D., … Pierelli, L. (2015).
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery:
Results of a prospective single-blind randomized controlled trial. Transfusion, 55(7),
1644–1654. https://doi.org/10.1111/trf.13027
Worldwide Health Organization [WHO]. (2008). Worldwide prevalence of anemia: 1993-2005.
Retrieved from
http://apps.who.int/iris/bitstream/handle/10665/43894/9789241596657_eng.pdf?ua=1
Yoo, Y.C., Shim, J.K., Kim, J.C., Jo, Y.Y., Lee, J.H., & Kwak, Y.L. (2011). Effect of single
recombinant human erythropoietin injection on transfusion requirements in
preoperatively anemic patients undergoing valvular heart surgery. The Journal of the
American Society of Anesthesiologists, 115(5), 929–937.

PREOPERATIVE ANEMIA MANAGEMENT
Appendices
Appendix A
The Burke and Litwin Model of Organizational Performance and Change

A model of organizational performance and change. Reprinted from “A causal model of
organizational performance and change,” by W. W. Burke and G.H. Litwin, 1992, Journal of
Management, 18(3), 528. Copyright 1992 by Southern Management Association.
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Organization IRB Determination
Available upon request.
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Appendix D
SWOT Analysis of the Preoperative Assessment Center
•
•
•
•
•
•

•
•
•

•
•

Strengths
Aesthetically pleasing building
Part of a Magnet designated hospital
system
Motivated leaders and staff that
support change projects.
Consistent providers that specialize in
preoperative assessment
Close relationship to the hospital
where surgeries take place
Cohesive pre-surgical optimization
visit
Opportunities
Blood shortage, need for management
to decrease the use of blood products
Has bandwidth to see more patients
Close relationship with hospitalists
and referring providers and anesthesia,
leads to effective communication
streams
Enhanced quality of care by
incorporating evidence-based practice.
A positive relationship between the
PAC practice manager and a local
infusion center

•
•
•

•
•
•
•

Weaknesses
Gaps in needed staff; need pharmacy,
dietician, and more advanced practice
providers
Lack of infusion chairs readily
available
Need additional staff to provide more
in-depth education classes.

Threats
Individual barriers to change,
unwillingness to change
Ordering infusions perceived as
confusing process at this organization
No current relationship with
cardiothoracic surgery.
Patients unable to get to infusion
clinic/pay for new iron infusion
supplements.
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PRISMA Flow Diagram of Systematic Search
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Appendix F
Table of Evidence

Articles included in review with author, year, purpose, design, inclusion, intervention comparisons, results, conclusions
Author (Year)
Design (N)
Inclusion Criteria
Intervention vs
Results
Purpose
Comparison
Yoo (2011)
Investigate
effect of a
single
preoperative
bolus of
erythropoietin
(EPO) on
perioperative
transfusion
requirement

Prospective,
single-site,
single
blinded,
randomized,
and parallelarm
controlled
trial N=74

Adults with
preoperative
anemia

Cladellas
(2012)
Investigate
whether the
combined
therapy (IV
rhEPO and
iron) before
valve

Before-andafter study:
RCT (Total
N=134; ,
anemic adults

Anemic adults
without
emergency
surgery, isolated
CABG

500IU/kg EPO and
200mg iron sucrose IV
1 day before surgery.
The control group
received an equivalent
volume of normal
saline.
Assessed transfusion
requirement during
surgery and 4 days
postop. Reticulocyte
count and iron profiles
were measured
serially and compared
preoperatively and on
post-op days 1, 2, 4,
and 7.
-Intervention started
1-month prior to
surgery, 500IU/kg/day
rhEPO was given
every week for four
weeks and the fifth
dose 48 hrs. before
surgery. During each
rhEPO session,

Conclusion

-Transfusion occurred in 86% of the
control group versus 59% of the
EPO group.
-The mean number of packed red
blood cells transfused per patient
and for 4 postoperative days was
decreased in EPO group versus the
control group (3.3 ± 2.2 vs 1.0 ± 1.1
units/patient).

A single IV
administration of
EPO and an iron
supplement 1 day
before surgery
reduced
perioperative
transfusions in
anemia patients
undergoing
valvular heart
surgery

-Therapy increased hemoglobin
concentration from 11.2 ± 1g/dL at
baseline to 12.6 ± 0.9 g/dL before
surgery.

Combined therapy
of IV rhEPO and
iron administered
before cardiac vale
replacement in
anemic patients
improved in
postoperative
outcomes and
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replacement
improved
postoperative
mortality and
morbidity; and
extent to which
aRBCt were
decreased.
Lin (2013)
Assess IV iron
efficacy to
reduce
perioperative
red cell
transfusions.

Systematic
review: 24
RCTs and 15
nonrandomized
trials
(N=4,417)
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patients received iron
infusion
supplementation (max
dose 200mg/day,
calculated by body
weight). Therapy was
stopped if hemoglobin
levels reached normal.
Adults
with -IV iron on anemia
anemia scheduled -EPO on anemia
for surgery, who -EPO + IV iron on
were not pregnant anemia
-Use of EPO and
IV iron in mgmt.
of perioperative
anemia

decreased in RBC
transfusions

- A short preoperative regimen of
EPO, or a single dose of EPO plus
IV iron in the preoperative or
intraoperative period may
significantly reduce transfusion
rates (number needed to treat to
completely avoid RBC transfusions
ranged from 3 to 6 infusions.)

-Increased
standardized
mean
hemoglobin concentration compared
with oral iron or no iron
supplementation (standardized mean
difference 6.5 g/L, 95% confidence
interval 5.1 g/L to 7.9 g/L)
-Reduced risk for blood transfusion
(risk ratio 0.74, 95% confidence
interval 0.62 to 0.88)
-Reduced risk ratio of requiring red
blood cell transfusion after IV iron
therapy.
-PO iron vs inactive -Required blood transfusions was
controls
reduced from 27.9% in the inactive

-Patients
with
preoperative iron
deficiency anemia
may have an earlier
and more robust
hemoglobin
recovery
with
preoperative
IV
iron therapy than
with oral iron
supplementation.

Litton (2013)
Evaluate
efficacy/safety
of IV on
hemoglobin,
requirement
for transfusion,
and risk of
infection

Systematic
review/metaanalysis (75
RCTs
N=10,879)

RCTs of IV iron -Change
in
compared
with hemoglobin
either no iron or -Infection
oral iron
-Transfusion
-Serious adverse event
-Mortality

IV iron increased
hemoglobin
concentration and
reduced risk of
allogeneic red
blood cell
transfusion

Gurusamy
(2014)

Cochrane
Review (21

Adults with mildmoderate anemia
who were not

-Oral iron
decreased those
proportion of
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Assess the
RCTs,
safety and
N=4745)
efficacy of iron
therapies for
the treatment
of adults with
anemia

pregnant/have
kidney disease

-IV iron vs inactive
controls (oral or IV
placebo)
-Compared different
iron preparations.

control group versus 20.6% in the
oral iron group
-Required blood transfusions was
reduced from 18.2% in the inactive
control group versus 15.3% in the
IV iron group
-Required blood transfusions was
reduced from 18.9% in the oral iron
group versus 11.5% in the IV iron
group
-Hemoglobin in the oral iron group
was 0.3 to 3.10 g/dL higher than the
inactive control group.
-Hemoglobin in the IV iron group
was 0.3 to 3.00 g/dL higher than the
inactive control group.
-Hemoglobin in the IV iron group
was 0.5 g/dL lower than the oral
iron group.
-17% (51/300) in HRE group
required PRBCs compared to 39%
(117/300) in the control
-HRE reduced the risk of PRBCs
44% compared to control.
-Low rate of potential HRE related
adverse events including infection,
thrombosis, hypertension, and renal
or neurologic complications.
-Mortality was similar between two
groups.

Weltert (2015)
Assess single
80,000IU dose
of human
recombinant
erythropoietin
(HRE) 2-days
before cardiac
surgery effect
on reducing
perioperative
allogeneic red
blood cell
transfusion.
Clevenger
(2016)

Prospective
single-blind
RCT
-Antiplatelet
and
anticoagulati
on stopped 5days prior to
surgery.
-Trigger
hemoglobin
level to
transfuse: 8.0

-Adults
undergoing heart
surgery at the
European Hospital
in Rome, Italy
with a hemoglobin
of less than 14.5
g/dL

-Received HRE vs
none
-Hemoglobin Baseline
vs post-operative day 4
-Baseline ferritin and
transferrin values to
assess
preoperative
iron metabolism.
-HRE related adverse
events 45-days’ postsurgery.

Cochrane
Review (64

-RCTs irrespective -Oral iron vs placebo -Oral and IV iron demonstrated
of
blinding, or no iron therapy
reduction in the risk of blood

people who
required blood
transfusion.
-IV iron results in
a modest increase
in hemoglobin
levels compared to
oral iron or
inactive control
without clinical
benefit.

Single high dose
of HRE
administered 2days before
cardiac surgery
reduced need for
PRBCs without
increasing adverse
events, reducing
transfusions.

IV iron improved
hemoglobin
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Assess efficacy RCTs,
and safety of
N=9,004)
iron therapies
for adults with
anemia

publication status
or date, study
setting, and sample
size.
-Any nonperipartum anemic
adults without
CKD

Peters (2018)
Investigate use
of IV iron in
the pre-/postoperative,
settings

English articles,
Measured hemoglobin
only studies with a levels, reticulocyte
control group
counts, and/or RBC
concentrates.

20 RCTs, 7
observational
trials, and 5
retrospective
studies

-IV iron vs placebo or
no iron therapy
-IV iron vs oral iron
-Various oral iron
formulations
and
doses compared to
each other
- Various IV iron
formulations, routes
(IM vs IV) and doses

transfusion when compared with
inactive control (risk ratio(RR)
0.66, 95% confidence interval (CI)
0.48-0.90; and RR 0.84, 95% CI
0.73-0.97, respectively).

compared to oral
or no treatment.
No reduction in
mortality. Reduced
blood transfusion
rates. Despite
showing a greater
hemoglobin
response than oral
iron, IV iron failed
to show any other
benefits over oral.
-Pre- increased hemoglobin levels IV iron use
0.4-1.2 g/dL, reduced RBC use
strongest in the
-The number of trials for IV iron in preoperative
the post-operative setting is low and setting, and an
further research is needed.
individual
treatment decision
post-operatively
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Appendix G
PARiHS Model

Adapted from “Enabling the implementation of evidence-based practice: a conceptual
framework,” by A. Kitson, G. Harvey, and B. McCormack. Copyright 1998 by Quality and
Safety in Health Care.
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Appendix H
Site Advisor Approval Letter
Available upon request.
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Appendix I
Kotter’s Eight Step Change Model

Adapted from “Kotter’s 8-Step Process”, by J. Kotter. Copyright 2017 by Kotter International
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Appendix J
Referral Process in Anemia Management for outpatient CABG
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Appendix K
Outpatient Anemia Algorithm

If Hgb < 13 for men or < 12 for women, first evaluate the CBC and MCV
(If this is first anemic CBC, encourage healthy diet and recheck in 3 months. If Hgb still low, proceed)

Normocytic (MCV 80-100)
Consider anemia of chronic disease,
renal insufficiency, hemolysis,
nutritional deficiency.

Microcytic (MCV < 80)
Check Ferritin, Iron and IBC Level

Ferritin < 30 mcg/L

Ferritin 31-99
mcg/L

Yes

TIBC > 400mcg/dL
OR Iron Level < 40mcg/dL
OR Iron Saturation < 15%

Iron Deficiency
See Treatment
Pathways Below

Macrocytic (MCV > 100)
Check Folate and Vitamin B12 levels

(Liver disease, hypothyroidism, metformin, phenytoin,
malnutrition can cause deficiency)
Folate < 4ng/mL

Ferritin > 100
mcg/L
Check
Iron, B12,
Folate
studies

No

Consider peripheral
smear for additional
workup (hematology
NormalifB12/folate
consult
Hgb < 10g/dL)

Check LDH,
haptoglobin

BOTH

B12 < 400pg/mL

Folate
(Must correct B12 first)
Daily MVI or suppl. with
1mg folate.
Can also increase leafy
greens, nuts, whole grain
cereals, banana intake

No Iron Deficiency
Consider
hematology consult

Treat
deficiency
as shown

If hemolysis
present, consult
hematology

Recheck in 3 months

Vitamin B12
Level 150-400pg/mL: B12
1000mcg PO daily OR
1000mcg IM monthly
Level < 150pg/mL: B12
1000mcg IM qWeek x4,
then 1000mcg PO daily OR
1000mcg IM monthly
- Recheck in 3 months
- Increase egg, meat, fish,
and dairy intake

Iron Replacement
Algorithm
Intravenous Ferric Carboxymaltose x 2 doses
< 50kg: 15mg/kg on day 1; repeat dose in 7-10 days
> 50kg: 750mg on day 1; repeat dose in 7-10 days
**Other relevant info here re: infusion center?**

Ferritin < 30 mcg/L
OR surgery/procedure
planned in next 3 months
OR new, severe symptoms
OR Hgb < 9g/dL

All Others

Ferrous Sulfate 325mg PO TID
- Take with water/juice on empty stomach
- GI upset common! Try taking with food
before discontinuing
- If taking antacids/H2RA/PPI:
* Take FeSO4 1 hour before acid-blocker
* Take FeSO4 with juice

Intolerance
to PO

No/Minimal
Improvement
Recheck
studies in
3 months

Improved/Corrected

Recheck
studies in
1-3 months

Not
Corrected

Fe Deficiency
Corrected

Ferrous Sulfate 325mg PO BID
Lifelong (?) as tolerated

Can repeat course if
anemia reoccurs

Routine
Outpatient
Monitoring
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Appendix L
Scripting Tip Sheet for CTS: Referral to PAC
Preoperative Assessment Center (PAC)
Scripting for Cardiothoracic Patients

Epic Referral Code: REF943 – Choose Butterworth location
Information for your patients why they are being referred to the SOC:

1.

Surgical Optimization Center
330 Barclay NE, Suite 104/ MC197
Grand Rapids, MI 49503
616.267.9823 fax 616.267.8414
Adam Edlund, MD, SFHM
Medical Director, Perioperative Medicine
adam.edlund@spectrumhealth.org

Why am I being referred to the PAC for medical evaluation and not my PCP?
Your surgeon has identified that your diagnosis of________ may put you at higher risk of post-operative complications. We
would like to optimize your ___(diagnosis)____prior to surgery to lower your risk for complications. Our goal is to make your
surgery as safe as possible. The PAC provides assessments of medically complex patients. The PAC providers work directly
with anesthesiology and your surgeon to ensure your safety for surgery. A thorough evaluation of your medical, surgical, family
history, and medications you are currently taking will better inform your surgeon of your risk of surgery. The PAC team will also
give you instructions on which medications you can take prior to your surgery. They will also order any appropriate testing or
lab work that may be needed. The PAC can also help arrange home health services, if needed, when you are home. All of this
information will be communicated to your surgeon and your PCP.

2.

Will this delay my surgery?
The PAC is efficient in evaluating your needs based on the type of surgery, anesthesia, and your medical history. It is
important that you are “optimized” or at your least risk possible of having complications during and after surgery. Other testing
may be ordered to ensure your safety. This may at times cause some delay. This will be communicated to your surgeon.

3.

What happens next?
A referral will be placed to the PAC by your surgeon. The PAC team will call you within 1-2 days to schedule your evaluation
with one of their providers, usually 2 weeks prior to surgery.

4.

What do I need to bring to my appointment at the SOC?
•
•
•
•

5.

A complete list of your medications and any over-the-counter medications, vitamins, and other supplements, including
how often you take them
Information about your medical conditions and prior surgeries
You do not have to fast for this appointment
The appointment will take approximately 45 minutes to 1 hour

Additional Information
•
When the PAC calls the patient to schedule their appointment we will go over all this information with them and send
them directions.
•
Any additional notes put into the EPIC referral from the cardiothoracic team is helpful
•
PAC team will communicate any patient concerns back to the cardiothoracic surgeon

1
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Appendix M
Post-Implementation CTS Provider Satisfaction Survey Tool
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in
outpatient CABG patients
1. This process change had no impact on my workflow.
Strongly Disagree

1

2

3

4

5

Strongly Agree

2. The referral process between the PAC and CTS was easy to navigate.
Strongly Disagree

1

2

3

4

5

Strongly Agree

3. The appointment at the PAC was convenient for my patients.
Strongly Disagree

1

2

3

4

5

Strongly Agree

4. The preoperative optimization of my patients at the PAC met my expectations.
Strongly Disagree

1

2

3

4

5

Strongly Agree

5. The communication between the PAC and CTS has met my expectations.
Strongly Disagree

1

2

3

4

5

Strongly Agree

6. I am likely to continue to refer my patients to the Preoperative Assessment Center for
preoperative management in the future.
Strongly Disagree

1

2

3

4

5

Strongly Agree

Any comments or ideas for improving the process: ____________________________________
______________________________________________________________________________
______________________________________________________________________________
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Appendix N
Post-Implementation PAC Provider Satisfaction Survey Tool
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in
outpatient CABG patients
1. This process change had no impact on my workflow.
Strongly Disagree

1

2

3

4

5

Strongly Agree

2. The referral process between the PAC and CTS was easy to navigate.
Strongly Disagree

1

2

3

4

5

Strongly Agree

3. Ordering iron infusions through Epic was an easy process to navigate.
Strongly Disagree

1

2

3

4

5

Strongly Agree

4. The communication between the PAC and CTS has met my expectations.
Strongly Disagree

1

2

3

4

5

Strongly Agree

5. I recognize the benefit of this referral process and am likely to continue to support it.
Strongly Disagree

1

2

3

4

5

Strongly Agree

Any comments or ideas for improving the process: ____________________________________
______________________________________________________________________________
______________________________________________________________________________
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Appendix O
Table of Measures
Concept
measured
Clinical
System
Change

Referral to PAC to
anemia workup
and treatment

Clinical
System
Change

Blood utilization

Patient
Outcomes

Sustainability

How
measured
(tool, survey,
variable)
Presence of
referral order
yes/no,
presence of
treatment
yes/no: one
sample test of
proportions

When measured

Who measures

December 2018March 2019,
throughout
implementation

DNP Student

Chart audits,
Blood
Utilization
Dashboard:
Wilcox Rank
Sum Test

December 2018March 2019,
throughout
implementation

DNP Student

Hemoglobin
change

Chart audits:
Wilcox Rank
Sum Test

December 2018March 2019,
throughout
implementation

DNP Student

Provider/clinician
satisfaction for the
process change

Survey: Likert
scale

PostImplementation

DNP
Student/CTS/PAC
Practice Manager
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Appendix P
CABG Patients Chart Audit Tool – Surgical Referral
Age: ______
Reviewer Name: __________________________
Questions
Does the patient have
a recent Complete
Blood Count done
PRIOR to a cardiac
catheterization?
Is the patient anemic
according to WHO
standards?
(Hemoglobin < 13 in
men; < 12 in women)
If anemic, were follow
up labs ordered based
on the MCV (iron
studies, vitamin B12,
folate, etc.)
Was referral to the
PAC made?
Was the patient’s
anemia
addressed/treated?
Surgery:
Was blood used
during surgery?
Was blood used after
surgery?

Chart Review Data
Yes

No

N/A

Yes

No

Hgb level prior to cardiac catheterization: ___

Yes

No

MCV: _____
If yes, what labs were ordered?: _______________
_________________________________________

Yes

No

N/A

Yes

No

If Yes, what treatment?: _____________________

N/A

N/A

Yes

No

Yes

No

Full name of surgery: _______________________
Date/Hgb prior to surgery: ___________________
If yes, type and quantity of blood used: _________
_________________________________________
Hgb after surgery:
If yes, type and quantity of blood used: _________
_________________________________________

Additional information: __________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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Project Budget
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Appendix R
Project Timeline

1

2

3

4

5

6

7

8

9

10

•Complete proposal and acceptance of project by faculty at GVSU and key stakeholders within the
organization by end of November 2018

•Present the proposed referral process to CTS and to the PAC by December 2018 for feedback and
comments.

•Collect current data on anemia in CABG patients using retrospective chart audits on the current state
of anemia management by November 30, 2018.

•Present and educate CTS and PAC on final referral process and information on the anemia managment
order set by December 2018.

•Additional lab work will be drawn if indicated to determine type of anemia. Anemic patients will be
referred to the PAC for management of anemia prior to CABG surgery after initial surgical consultation
for the implementation period of December 2018 through February 2019.

•Send weekly progress reports on the progress of the new process to key stakeholders during project
implementation, December 2018 through February 2019.

•Collect post-implementation data under the new process (December 2018-February 2019) and the
deliver final report to appropriate healthcare providers by March 2019.

•Deliver final reports to site mentor, practice managers, medical directors, and key stakeholders by
March 2019.

•Give a post-implementation survey regarding provider satisfaction to help clarify added value and
process sustainability in March 2019.

•Present results during April 2019 staff meeting, and give credit to all staff members who were involved
with the project
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Appendix S
Results: Anemic Outpatient CABG Patients Treated

Treated if Anemic

Treated

0%

10%

20%

30%

After implementation

40%

50%

Before implementation

60%

70%
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Appendix T
Results: Blood Usage for Intervention and Usual Care Groups

Intervention group Blood Usage
Units of Blood Used
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Group 2 Blood Usage
Units of Blood Used
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Appendix U
Results: Post-Implementation Provider Survey Results

CTS Provider Post Implementation Survey
5
4
3

5
4

2

3

4

3

4

3
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PAC Provider Post Implementation Survey
5

5

4

3

4

3

3

2

4

4

3

4

3

2

1
Q1

Q2

Q3
Provider 1
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PowerPoint Doctoral Defense Presentation

Preoperative Anemia
Management in Adult
Outpatient Coronary
Artery Bypass Graft
Surgical Patients to
Improve Treatment of
Preoperative Anemia
Katherine Mills
DNP Project Defense
April 15, 2019
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Objectives for Presentation
1. Review the clinical problem: preoperative anemia
within the context of the organizational assessment
2. Review the literature review and proposed solution
3. Review the project plan, including theoretical
models
4. Present results and sustainability plan
5. Discuss implications for practice, DNP essentials,
and dissemination plan

Introduction
• Anemia: Hemoglobin concentration of less than 12 g/dL in
non-pregnant women and less than 13 g/dL in men.
• Almost 50% of anemia is due to iron deficiency (World Health
Organization, 2008)

• Anemia and red blood cell transfusions (aRBCt) are
independently associated with poor outcomes after cardiac and
non-cardiac surgery (Clevenger et al., 2016; ; dos Santos et al., 2013;
Hung, Besser, Sharples, Nair, & Klein, 2011; Shander et al., 2010)

• Preoperative anemia is common among cardiac surgical
patients à more likely to need blood transfusion in the
perioperative period.
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Project Purpose
• To implement an evidence-based practice
improvement initiative to improve the
treatment of iron deficiency anemia prior to
coronary artery bypass (CABG) surgery in a
large Midwestern health system (MHS) by
restructuring the preoperative optimization
process.
• Cardiothoracic Surgery (CTS) – Preoperative
Assessment Center (PAC) collaboration

Organizational
Assessment
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IRB Approval
• Site Institutional Review Board (IRB)
• Scope limited to quality improvement

• GVSU Human Research Review Committee
• Project not defined as research

Assessment of Organization
• Organizational assessment completed between MayAugust 2018
• Burke and Litwin Model (1992)
• Assessment included:
– External factors (blood scarcity)
– PAC & CTS: # providers and staff, # patients, and
bandwidth, readiness for change
– Cardiovascular Medicine: process of referral to CTS
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Assessment of Organization

The Burke and Litwin Model of Organizational
Performance and Change (1992) (Burke & Litwin, 1992)

SWOT - PAC
Strengths
•
•
•
•
•
•

Aesthetically pleasing building
Part of a Magnet designated hospital system
Motivated leaders and staff that support change
projects.
Consistent providers that specialize in
preoperative assessment
Close relationship to the hospital where surgeries
take place
Cohesive pre-surgical optimization visit

Weaknesses
•
•
•

Opportunities
•
•
•

•
•

Blood shortage, need for management to decrease
the use of blood products
Has bandwidth to see more patients
Close relationship with hospitalists and referring
providers and anesthesia, leads to effective
communication streams
Enhanced quality of care by incorporating evidencebased practice
A positive relationship between the PAC and
other surgery practices in the organization

Gaps in needed staff; need pharmacy, dietician, and
more advanced practice providers
Lack of infusion chairs readily available
Need additional staff to provide more in depth
education classes.

Threats
•
•
•
•

Individual barriers to change, unwillingness to
change
Ordering infusions is a confusing process at this
organization
No current relationship with cardiothoracic surgery.
Patients unable to get to infusion clinic/pay for new
iron infusion supplements.
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Key Stakeholders
• CTS personnel (surgeons, schedulers, RNs,
clinical practice managers)
• PAC personnel (medical director, nurse
practitioners, practice manager, medical
assistants, educators)
• Site pharmacists, infusion clinic staff,
cardiovascular medicine staff, quality
improvement specialists

Current State – Outpatient Referral
• Patient is identified as having multivessel disease
following diagnostic heart catheterization
• Referral to CTS is made
• CT Surgeon meets with patient
• Surgery is scheduled within 2-3 weeks.
• The patient is referred to their primary care provider
for preoperative assessment

81

PREOPERATIVE ANEMIA MANAGEMENT

Society of Thoracic Surgery (STS)
Adult Cardiac Surgery Registry
• 38% of all patients at MHS who undergo cardiac
surgery are anemic at the time of surgery.
• Further, approximately 30% of MHS patients
from the outpatient setting who undergo CABG
surgery are anemic
• Of this 30%, only 17% of anemic, outpatient
CABG patients were identified as anemic prior to
surgery and were given treatment at MHS.

Clinical Practice Question
• If patients are referred to a preoperative
assessment center prior to CABG surgery for
preoperative anemia work-up, will the number
of patients undergoing CABG surgery with
untreated anemia decrease?
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Literature Review

Literature Review Aims
• Typical treatment for iron deficiency: iron
supplementation and erythropoietin (EPO)
• To determine best practice for preoperative anemia
management:
– Does any formulation of iron supplementation therapy
increase hemoglobin concentration in anemic patients?
– What formulation of iron supplementation is safe and
effective in improving hemoglobin levels in anemic
patients?
– What formulation of iron supplementations reduces the risk
of aRBCt in anemic patients?
– Is EPO therapy safe and efficacious in reducing the use of
aRBCt in cardiac surgery?
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Review Method
• PRISMA guidelines served as the framework
for the review. (Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009)
• Keywords included: anemia, preoperative anemia,
cardiac surgery, anemia management, cardiac, adult,
iron infusion, erythropoietin, systematic review,
meta-analysis, and randomized control trial.

PRISMA
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Literature Review
• Included:
–
–
–
–

Two Cochrane Reviews
Two systematic reviews
Three randomized control trials (RCT)
One comprehensive review article
(Clevenger et al., 2016; Gurusamy et al., 2014)

(Lin et al., 2013; Litton et al., 2013)

(Cladellas et al., 2012; Weltert et al., 2015; Yoo et al., 2011)

(Peters et al., 2018)

• Conclusion: Iron therapy and/or EPO to correct
preoperative anemia is both safe and efficacious.
(Clevenger et al., 2016; Gurusamy, Nagendran, Broadhurst, Anker, & Richards,
2014; Lin, Lin, & Tran, 2013; Litton, Xiao, & Ho, 2013; Peters et al., 2018)

Literature Review Results Summary
• The authors of all eight articles described a
decrease in blood transfusion requirements
after iron supplementation and/or EPO
injection (Clevenger et al., 2016; Gurusamy et al., 2014; Lin et al., 2013; Litton et al., 2013;
Cladellas et al., 2012; Weltert et al., 2015; Yoo et al., 2011; Peters et al., 2018)

• The authors of five studies measured an
increase in hemoglobin after the use of
preoperative IV iron supplementation (Clevenger et al.,
2016; Gurusamy et al., 2014; Lin et al., 2013; Litton et al., 2013; Peters et al., 2018)

• The authors of three studies saw a decrease in
mortality (Clevenger et al., 2016; Cladellas et al., 2012; Weltert et al., 2015)
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Evidence for Project
• Anemia is associated with worse outcomes and
increased mortality after cardiac and noncardiac surgery
• Correcting anemia prior to surgery may
decrease the risk of blood transfusion
associated adverse events and shorten length
of hospital stays
• Correcting preoperative anemia is safer for
patients and cost effective.
(Clevenger et al., 2016)

(Clevenger et al., 2016; Cladellas et al., 2012)

(Shander, et. al., 2010)

Phenomenon Conceptual Model PARiHS

Adapted from “Enabling the implementation of evidence based practice: a
conceptual framework,” by A. Kitson, G. Harvey, and B. McCormack. Copyright
1998 by Quality and Safety in Health Care. (Kitson, Harvey, & McCormack, 1998)
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Project Plan

Project Objectives
1. Introduce a new referral process to the PAC for
CABG patients to treat anemia and other
comorbidities
2. Improve the treatment of anemia in perioperative
setting among CABG patients
3. Provide evidence that the referral process
increased treatment of anemia in CABG patients
4. Evaluate provider satisfaction to clarify added
value and sustainability
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Project Purpose
• Purpose: implement an evidence-based
practice improvement initiative to improve the
treatment of iron deficiency anemia prior to
CABG surgery at MHS by restructuring the
preoperative optimization process.

Design
• Quality improvement project
• The implementation process was guided by
Kotter’s eight steps of change
(Kotter, 1996)

– Three phases
• Creating climate for change
• Engaging and enabling the organization
• Implementing and sustaining for change
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Implementation Model - Kotter

Adapted from “Kotter’s 8-Step Process”, by J. Kotter.
Copyright 2017 by Kotter International (Kotter, 1996)

Setting & Participants
• The PAC offers a standardized approach to
preoperative medical evaluation and
management to avoid preventable
complications and mortality
• Participants:
– Outpatient CABG candidates
– Healthcare providers (RNs, APPs, cardiologists,
cardiothoracic surgeons, MAs)
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Implementation Strategy & Elements
(Powell, et al., 2015)

Assess
Readiness

Build
Coalition

Develop
Education

• Organizational assessment
• SWOT analysis
• Shadowing experiences

• Building positive relationships
• Gathering key stakeholders
• Forming subcommittees

• Strategies for provider education
• Presenting initial process draft to key stakeholders
• Educate CTS/PAC on new pilot assessment process
for CABG patients

May-July
2018

May-Nov
2018

Oct - Dec
2018

Implementation Strategy & Elements
(Powell, et al., 2015)

• Patients will be referred to PAC after initial surgical
Dec 2018consult
Feb 2019
•
CTS
will
order
the
additional
laboratory
studies
needed
Conduct
Change Tests • PAC will optimize patient for surgery, will order anemia treatment

Provide
Feedback

Share
Knowledge

• Weekly progress reports to providers on progress of
pilot project
• Post-implementation data will be collected

• Final project results shared with key stakeholders
• Post-implementation satisfaction survey distributed and
collected

Dec 2018Mar 2019

Mar 2019
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Timeline
1

• Complete proposal and acceptance of project by faculty at GVSU and key stakeholders
within the organization by end of November 2018

2

• Present the proposed referral process to CTS and to the PAC by December 2018 for
feedback and comments.

3

• Collect current data on anemia in CABG patients using retrospective chart audits on the
current state of anemia manamgent by November 30, 2018.

4

• Present and educate CTS and PAC on final referral process and information on the
anemia management order set by December 2018.

5

• Send weekly progress reports on the progress of the new process to key stakeholders
during the project implementation for nine weeks during project implementation.

6

• Collect post-implementation data under the new process (December 2018-February
2019) and the deliver final report to appropriate healthcare providers by March 2019.

7

• Deliver final reports to site mentor, practice managers, medical directors, and key
stakeholders by March 2019.

8

• Give a post-implementation survey regarding provider satisfaction to help clarify added
value and process sustainability in March 2019.

9

• Present results during April 2019 staff meeting, and give credit to all staff members who
were involved with the project

Referral Process to PAC
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Outpatient Anemia Algorithm

Evaluation & Measures
Concept measured

How measured

When measured

Who measures

(tool, survey, variable)
Referral to PAC to
anemia workup and
treatment

Presence of referral order yes/no,
presence of treatment yes/no

December 2018-March
2019, throughout
implementation

DNP Student

Blood Utilization

A comparison of a random sample
of 10 patients (usual care group)
not involved in the pilot project
compared to the intervention
group
Average post-operative
hemoglobin in the intervention
group and the average postoperative hemoglobin in the usual
care group (n=10)
Survey

December 2018-March
2019, throughout
implementation

DNP Student

December 2018-March
2019, throughout
implementation

DNP Student

Post-Implementation

DNP
Student/CTS/PAC
Practice Manager

Post-Operative
Hemoglobin Change

Provider/clinician
satisfaction for the
process change
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Analysis Plan
• Data will be analyzed with support of university
graduate student statistician.
– One sample test of proportions: The proportion of patients
entering surgery treated for anemia pre- and postimplementation
– Wilcox Rank Sum Test:
• A comparison of blood product usage of a random sample of 10
patients (usual care group) not involved in the pilot project
compared to the intervention group (n=14)
• Average post-operative hemoglobin in the intervention group
(n=14) and the average post-operative hemoglobin in the usual
care group (n=10).

• Sustainability: Post-implementation survey regarding
provider satisfaction

Results
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Results: Participant Characteristics
– Intervention Group: Patients involved in the pilot
project that were screened using new referral process
(n=14)
• Average age: 63.8 years; 21.4% female

– Usual Care Group: Random sample of elective
CABG patients that were not involved in the pilot
project (n=10)
• Average age 68.8 years; 10% female

– One surgeon’s elective CABG patients were screened
for full 12 weeks of implementation, another surgeon’s
elective CABG patients screened for last four weeks of
implementation.

Results: Patients Screened
• 14 patients total screened in Intervention Group
• 42.86% (6 of 14) were anemic at the time of
surgical consultation
– 83.3% (5 of 6) were properly referred
– 66.6% (4 of 6) were treated, compared to 17% (7 of
41) of anemic outpatient CABG patients preimplementation (p=0.006)

• 49.6% (17% to 66.6%) increase in anemia
treatment
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Results: Anemic Outpatient CABG Patients Treated
Treated if Anemic

Treated

0%

10%

20%

30%

40%

After implementation

50%

60%

70%

Before implementation

Intervention Group Blood Usage
8

7

6

14 aRBCt used in total

5
4
3

2

2
1
0

2

1
0000
P1

1
00

P2

1

1

000

000

000

000 0000 0000 0000 0000 0000 0000

000 0000

P3

P4

P5

P6

P13

P7

P8

P9

P10

PRBCs

Platets

FFP

P12

P14

Cryo

Usual Care Group Blood Usage
3

6 aRBCt used in total
22

2

2

1

1

0

0000

0000

0000

P1

P2

P3

0

1

00
P4

00
P5

0000

0000

P6

P7

Patients

(p=1)

P11

Patients

Units of Blood Used

Results:
Blood
Product
Usage

Units of Blood Used

7

PRBCs

Platelets

FFP

Cryo

000
P8

000
P9

0000
P10
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Results: Post-Operative Hemoglobin
Total Average Post-Operative Hemoglobin
Intervention Group

Usual Care Group

(42.9% (6 of 14) anemic patients)

(20% (2 of 10) anemic patients)

10.3 g/dL

10.1 g/dL
p=0.62

• There is a clinically significant difference in the postoperative hemoglobin. This slight rise in hemoglobin,
despite the high number of anemic patients, is reason
enough to continue the process.

Post-Implementation CTS Survey
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in outpatient CABG patients
1.

2.

3.

This process change had no impact on my workflow.
Strongly Disagree
1
2
3

4

5

Strongly Agree

The referral process between the PAC and CTS was easy to navigate.
Strongly Disagree
1
2
3
4
5

Strongly Agree

The appointment at the PAC was convenient for my patients.
Strongly Disagree
1
2
3
4

Strongly Agree

5

4.

The preoperative optimization of my patients at the PAC met my expectations.
Strongly Disagree
1
2
3
4
5
Strongly Agree

5.

The communication between the PAC and CTS has met my expectations.
Strongly Disagree
1
2
3
4
5
Strongly Agree

6.

I am likely to continue to refer my patients to the Preoperative Assessment Center for preoperative management in
the future.
Strongly Disagree

1

Any comments or ideas for improving the process:

2

3

4

5

Strongly Agree
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Post-Implementation CTS Survey Results
CTS Provider Post Implementation Survey

1=strongly Disagree to 5=Strongly Agree

5

4

3

2

1
Surgeon 1
Surgeon 2

Q1
3
3

Q2
5
2

Q3
4
3

Q4
4
3

Q5
2
3

Q6
4
4

Likert Scale: 1=Strongly Disagree; 5=Strongly Agree
Q1-Workflow Impact
Q2-Referral Process
Q3-Conveniency
Q4-Expectation
Q5-Communication
Q6-Continuation

Post-Implementation PAC Survey
Satisfaction Survey for Sustainability: Referring to the PAC for preoperative management in outpatient CABG patients
1.

2.

3.

This process change had no impact on my workflow.
Strongly Disagree
1
2
3

4

5

Strongly Agree

The referral process between the PAC and CTS was easy to navigate.
Strongly Disagree
1
2
3
4
5

Strongly Agree

Ordering iron infusions through Epic was an easy process to navigate.
Strongly Disagree
1
2
3
4
5

Strongly Agree

4.

The communication between the PAC and CTS has met my expectations.
Strongly Disagree
1
2
3
4
5
Strongly Agree

5.

I recognize the benefit of this referral process and am likely to continue to support it.
Strongly Disagree
1
2
3
4
5
Strongly Agree

Any comments or ideas for improving the process:
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Post-Implementation PAC Survey Results
PAC Provider Post Implementation Survey

1=Strongly Disagree to 5=Strongly Agree

5

4

3

2

1
Provider 1
Provider 2

Q1
3
2

Q2
5
3

Q3
4
3

Q4
4
3

Q5
4
4

Likert Scale: 1=Strongly Disagree; 5=Strongly Agree
Q1-Workflow Impact
Q2-Referral Process
Q3-Ording Infusions
Q4-Communication
Q5-Continuation

Discussion
• 49.6% increase in anemia treatment
• aRBCt usage: no statistical change
– One patient outlier in Intervention Group, used 7 aRBCt
alone

• Post-op hemoglobin improvement: clinical
significance
– 50% (2 of 4) were treated with IV iron: increase in IV
iron use for more robust hemoglobin recovery post-op (Lin
et al., 2013)

• Provider Satisfaction: all providers surveyed willing
to continue the new referral process
• In addition to anemia treatment, patients also
received assessment of chronic disease from PAC

PREOPERATIVE ANEMIA MANAGEMENT

Limitations
• Short implementation period
• Small sample size
– Unable to generalize findings
– Difficult to evaluate statistical significance

• Referred two surgeon’s CABG patients only,
smaller than originally anticipated
• CTS scheduler on leave, less than expected buy-in
from new staff
• In future:
– Evaluate perioperative blood loss
– Survey nursing staff members, not just providers

Resources
& Budget
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Implications for Practice
• Referral to the PAC resulted in successful
treatment of iron deficiency anemia for
preoperative CABG patients
• Referral to the PAC will expedite management
of anemia as well as other chronic conditions
impacting surgical outcomes

Sustainability Plan
• This referral process on anemia management
in CABG patients will remain in place after the
completion of this project.
– Potential for expanding into different CTS
procedures.
– Large buy-in from leaders
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Dissemination
• Shared results with leadership and participants
of CTS and PAC on April 10, 2019
• Project presented at open forum poster
showcase at the organization in April 2019
• Final draft to be published in ScholarWorks©

Conclusions
• A Midwest health organization sought to increase
anemia treatment prior to CABG surgery
• Organizational assessment and literature review
were conducted
• New referral process for CABG patients was
implemented with a CTS and PAC collaboration
• Treatment of anemia increased by 49.6% for
patients following the treatment pathway
• Project workflow and treatment algorithm have
been adopted as standard work for anemic
patients requiring cardiothoracic surgery
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DNP Essentials Reflection
I. Scientific Underpinnings for Practice
– Evidence-based treatment through literature review: Oral
iron IV iron, Epogen
– Use of PARiHS and Kotter’s 8-Step Change Model

II. Organizational and Systems Leadership
– Performing organizational needs assessment
– Cost analysis performed
– Obtained IRB approval from MHS and GVSU

III. Clinical Scholarship and Analytical Methods
–
–

Research based interventions.
Dissemination of results

DNP Essentials Reflection
IV. Information Systems/Technology
–
–

Use of a quality dashboard for blood utilization
Regular chart audits

V. Advocacy in Health Care Policy
–

Change in standard practice at CTS and PAC

VI. Interprofessional Collaboration
–

Collaborated with numerous disciplines (pharmacy,
surgeons, APPs, RNs, clinical program specialists,
quality improvement specialists)
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DNP Essentials Reflection
VII. Clinical Prevention Population Health
– Focused on CABG patient population – specific
needs relating to anemia.

VIII. Advanced Nursing Practice
– Developed partnerships with providers
– Facilitator for project
– Implementation of evidence-based intervention
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